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NANO-SIZED OPTICAL FLUORESCENCE 
LABELS AND USES THEREOF 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
The present invention relates to the creation of new classes 
of fluorescent/luminescent probes based on metal cluster 
fluorescence, methods of preparing such probes, and methods 
of use thereof. 
2. Background Art 
Single molecule fluorescence microscopy studies present 
an extreme limit in which weak signals must be observed on 
essentially zero background. Such optical methods relying on 
high-intensity laser excitation of highly emissive and robust 
fluorophores require extremely efficient background rejec-
tion. Relying on the introduction of artificial labels to identify 
the particular protein or structure of interest, fluorescence 
based methods suffer from two additional problems-pho-
tobleaching (loss of signal due to probe destruction) and 
autofluorescence (naturally occurring background fluores-
cence from native species within biological media). Even 
with these problems, fluorescence microscopy remains the 
primary optical method with potential for single molecule 
and chemical sensitivity while imaging biological media. 
Most in vitro fluorescent labeling is performed through 
standard chemical coupling of either N-succinimidyl ester-
conjugated dyes to free, solvent-exposed amines (often on 
lysine residues) or maleimide-conjugated dyes to thiols on 
either naturally occurring or genetically introduced solvent-
exposed cysteines. These two coupling chemistries continue 
to be extremely useful in attaching small, highly fluorescent 
dyes to proteins of interest. Such fluorescent biomaterials are 
then adequate for in vitro single molecule studies, or they can 
be re-introduced into cells in high concentration either 
through microinjection or other membrane transport methods 
to perform bulk fluorescence studies of the protein of interest 
within whole cells. Not only can protein function be altered 
both by the size and point of attachment of the fluorescent 
label, but also often because of the coupling chemistry used, 
the site of the fluorescent labeling is not accurately known. 
Thus, the smallest possible genetically programmed label 
would be highly advantageous. 
Additionally, in biological systems, the autofluorescent 
background from flavins, porphyrins, and all other weakly 
fluorescent naturally occurring species can produce a large 
background that interferes with laser-induced fluorescence 
signals. Because of these problems, studying dynamics of few 
copies of proteins within living systems requires the devel-
opment of new fluorescent probes that absorb and emit so 
strongly and without significant photobleaching such that 
they can be easily observed with extremely weak incoherent 
illumination for long times. Such illumination would enable 
preferential excitation of the fluorophores of interest relative 
to that of weak background signals. Additionally, the weaker 
illumination would preserve biological viability by minimiz-
ing phototoxicity effects. Unfortunately, single molecule sen-
sitivities are as of yet difficult to attain in such high back-
ground in vivo studies and are often difficult to observe even 
in lower background in vitro studies. 
Because of signal to noise constraints, single molecule 
studies are limited to fluorescence-based assays with all its 
associated difficulties. While single molecule methods have 
been effective in "peeling back" the ensemble average to 
examine environmental and mechanistic heterogeneity, cur-
rent techniques require expensive laser-based equipment, 
2 
specialized synthetic methods, and are still fundamentally 
limited by the poor optical properties or bioincompatibility of 
available fluorescent labels. 
Several key experiments have uniquely demonstrated the 
5 ability of single molecule microscopies to unravel the crucial 
steps leading to biological activity (Lu et al., Science 1998, 
282:1877-1882; Dickson et al., Nature 1997, 388:355-358; 
Funatsu et al., Nature 1995, 374:555-59; Ha et al., Proc. Nat. 
Acad. Sci., USA 1996, 93, 6264-6268; Vale et al., Nature 
10 1996, 380:451-453; Deniz et al., Proc. Natl. Acad. Sci., USA 
2000, 97:5179-5184; Ha et al., Proc. Natl. Acad. Sci. USA 
1999, 96:893-898; Harada et al., Biophys. J. 1999, 76:709-
715; Kinosita, Biophys. J. 2000, 78:149Wkshp). Most dra-
matic in studies of individual motor protein motion, mecha-
15 nistic insights into protein function and substeps within 
biomechanical cycles can be directly visualized, without the 
need of difficult external synchronization (Funatsu et al., 
Nature 1995, 374:555-59; Vale et al., Nature 1996, 380:451-
453; Kinosita, Biophys. J. 2000, 78:149Wkshp; Yanagida et 
20 al., Curr. Opin. Cell Biol. 2000, 12:20-25). Even biomolecule 
folding has been probed to unravel pathways leading to both 
misfolded and folded states (Deniz et al., Proc. Natl. Acad. 
Sci., USA 2000, 97:5179-5184; Ha et al., Proc. Natl. Acad. 
Sci. USA 1999, 96:893-898). Now that orientational (Bartko, 
25 &Dickson, J. Phys. Chem. B 1999, 103:3053-3056; Bartko& 
Dickson, J. Phys. Chem. B 1999, 103:11237-11241; Bartko et 
al., Chem. Phys. Lett. 2002, 358:459-465; Hollars & Dunn, J. 
Chem. Phys. 2000, 112:7822-7830) and fluorescence reso-
nance energy transfer (FRET) methods (Weiss, Science 1999, 
30 283: 167 6-1683) have been developed on the single molecule 
level, many more experiments are now possible. Unfortu-
nately in all single molecule studies, researchers are relegated 
to artificial fluorescent labeling of proteins of interest and 
limited to in vitro observation. Re-introduction of labeled 
35 proteins into the cell has yet to produce viable in vivo single 
molecule signals due to the large autofluorescent background 
and poor photostability of organic fluorophores. 
Single molecules also have many inherently undesirable 
properties that limit the timescales of experiments. Excitation 
40 rates must be very high to yield biologically relevant infor-
mation with reasonable time resolution (ms to seconds) and 
good signal to noise. Because the absorption cross-section 
(i.e. extinction coefficient, E) of the best organic fluorophores 
is only-10-16 cm2 (i.e. E-105 M- 1 cm- 1) at room temperature 
45 (Macklin et al., Science 1996, 272:255-258), high intensity 
laser excitation must be utilized for single molecule fluores-
cence studies.Additionally, organic molecules can only with-
stand -107 excitation cycles before they photochemically 
decompose (Dickson et al., Nature 1997, 388:355-358; Lu & 
50 Xie, Nature 1997, 385:143-146; Macklin et al., Science 1996, 
272:255-258). At 106 excitations/second (using -5 kW/cm2 
excitation intensity and a typical collection/detection effi-
ciency of5%), this limits the time resolution to-1 ms (with an 
idealized signal to noise ratio of - 7), and the average total 
55 time to follow an individual molecule before photo bleaching 
of -10 seconds. While this can be a very large amount of data 
on very biologically relevant timescales, many of the excita-
tion cycles end up being consumed by finding the molecules 
of interest before collecting data. Clearly, while reduction of 
60 oxygen can often increase the time before photobleaching, 
the photo stability and overall brightness of the organic dyes 
limit all biological single molecule experiments. Thus, 
advances in fluorophore properties will be crucial to the con-
tinued success of all single molecule optical studies in bio-
65 logical systems. 
Requiring similar coupling chemistry to that of organic 
fluorophores, water soluble II-VI quantum dots have recently 
US 7,611,907 B2 
3 
been proposed and demonstrated as biological labels 
(Bruchez et al., Science 1998, 281:2013-2016; Chan & Nie, 
Science 1998, 281:2016-2018; Zhang et al., Analyst 2000, 
125: 1029-1031). Materials such as CdSe with protective and 
stabilizing ZnS overcoatings have size dependent optical 5 
properties and can be synthesized with very narrow size dis-
tributions (Murray et al., Z. Phys. D-Atoms Mo!. Clusters 
1993, 26:S231-S233; Murray et al., J. Am. Chem. Soc. 1993, 
115:8706-8715; Peng et al., Nature 2000, 404:59-61). The 
strong absorption, spectral stability, and size-tunable narrow 10 
emission of these nanomaterials suggest exciting possibilities 
in biolabeling once further chemistry on the outer ZnS layer 
is performed to make these materials water-soluble (Rod-
riguez-Viejo et al., J. Appl. Phys. 2000, 87:8526-8534; Dab-
bousi et al., J. Phys. Chem. B 1997, 101:9463-9475).Because 15 
surface passivation is incredibly important in overall quan-
tum dot optical properties, much care must be spent on quan-
tum dot surface passivation and derivitization such that they 
can be reproducibly conjugated to proteins with predictable 
optical responses (Bruchez et al., Science 1998, 281:2013- 20 
2016; Chan & Nie, Science 1998, 281:2016-2018; Rod-
riguez-Viejo et al., J. Appl. Phys. 2000, 87:8526-8534; Dab-
bousi etal., J. Phys. Chem. B 1997, 101:9463-9475; Nirmal& 
Brus, Acc. Chem. Res. 1999, 32:407-414; Nirmal et al., 
Nature 1996, 383:802-804). In fact, successful implementa- 25 
ti on of water solubilization and surface passivation are only 
now beginning to bear fruit (Dubertret et al., Science 2002, 
298: 1759-1762; Jaiswal et al., Nat. Biotechnol. 2003, 21 :47-
51; Wu et al., Nat. Biotechnol. 2003, 21:41-46; Sutherland, 
Curr. Opin. Solid State Mat. Sci. 2002, 6:365-370; Gao et al., 30 
J. Biomed. Opt. 2002, 7:532-537; Mattoussi et al., J. Am. 
Chem. Soc. 2000, 122:12142-12150). 
While quite promising due to their bright and very narrow 
size-dependent emission, multiple problems with using CdSe 
as biological labels still exist. Their synthesis requires high 35 
temperature methods using highly toxic precursors, they are 
comparable to the size of proteins that they may label (2-6 nm 
in diameter), and they suffer from the same need to externally 
label proteins of interest and possibly re-introduce the labeled 
proteins into cells. Thus, while the strong oscillator strengths 40 
enable quantum dots to be easily observed with weak mercury 
lamp excitation, thereby avoiding much of the more weakly 
absorbing autofluorescent background, they are still not an 
ideal solution to in vivo or in vitro single molecule studies. 
4 
Garcia-Parajo et al., Proc. Natl. Acad. Sci., USA 2000, 
97:7237-7242; Cotlet et al., Chem. Phys. Lett. 2001, 336, 
415-423; Lounis et al., J. Phys. Chem. B 2001, 105:5048-
5054; Garcia-Parajo et al., Pure Appl. Chem. 2001, 73:431-
434; Garcia-Parajo et al., ChemPhysChem 2001, 2:347-360; 
Garcia-Parajo et al., Proc. Natl. Acad. Sci., USA 2001, 
98:14392-14397; Blum et al., Chem. Phys. Lett. 2002, 362: 
355-361). 
In one of the first such studies, GFP's blinking and optical 
switching abilities have been studied as photons were used to 
shuttle the GFP chromophore between two different optically 
accessible states (Dickson et al., Nature 1997, 388:355-358). 
Unfortunately, while GFP can be specifically attached to the 
N or C terminus of any protein and expressed in vivo as a 
highly fluorescent label, problems, especially on the single 
molecule level, still remain. GFP is 27 kD or -4 nm in diam-
eter (Ormo et al., Science 1996, 273:1392-5; Cubitt et al., 
Trends in Biochem. Sci. 1995, 20:448-55), and can therefore 
be a large perturbation to the protein to which it is attached. In 
addition, emission only occurs once GFP has folded into its 
final conformation, a process that can take up to -1 hour and, 
while examples of GFP labeling have been reported within all 
regions of different cells, sometimes GFP does not properly 
fold under a given set of conditions (Heim, Proc. Nat. Acad. 
Sci, USA 1994, 91:12501-04; Cubitt et al., Trends in Bio-
chem. Sci. 1995, 20:448-55). Additionally, when considering 
single molecule studies, its emission significantly overlaps 
with the autofluorescent background, but its emission inten-
sity is only comparable to standard exogenous organic dyes, 
thereby making in vivo single molecule studies very chal-
lenging. While largely insensitive to oxygen, it also typically 
bleaches after -107 excitation cycles, similar to standard 
organic dyes (Dickson et al., Nature 1997, 388:355-358). 
DsRed partially circumvents the issue of overlap with autof-
luorescent background, but while the red-shifted emission of 
DsRed relative to that of GFP could be an advantage, its 
comparable fluorescence intensity and tendency to form qua-
druplexes even at extremely low concentrations may further 
limit its use as an ideal biological label (Lounis et al., J. Phys. 
Chem. B 2001, 105:5048-5054; Garcia-Parajo et al., ChemP-
hysChem 2001, 2:347-360; Verkhusha et al., J. Biol. Chem. 
2001, 276:29621-29624; Sacchetti et al., FEBS Lett. 2002, 
525:13-19). Thus, the ideal label would combine the strong 
absorption, emission, and photostability of inorganic quan-
tum dots, the small size and simple attachment chemistry of 
organic dyes, or preferably, like GFP and DsRed, the ability to 
be expressed in vivo as a single molecule biological label 
attached to any protein of interest without first purifying, 
labeling, and re-injecting the protein. 
In summary, while current labeling methods and materials 
have enabled myriad bulk studies and many in vitro single 
molecule experiments, single molecule experiments remain 
limited by the disadvantages of even the best fluorescent 
probes. There is a need in the art for new single molecule 
Ideally, one would want the smallest possible genetically 45 
programmed label to be expressed on or adjacent to the pro-
tein of interest. Such an ideal label would need to have suffi-
ciently strong absorption and emission as well as outstanding 
photostability to enable long time single molecule observa-
tion with high time resolution, even in the presence of high 50 
background fluorescence. Such a fluorescent probe does not 
yet exist. Currently the best available options due to being 
composed solely of amino acids, green fluorescent protein 
(GFP; Dickson et al., Nature 1997, 388:355-358; Heim, Proc. 
Nat.Acad. Sci, USA 1994, 91:12501-04; Ormo eta!., Science 
1996, 273: 1392-5; Chattoraj et al., Proc. Nat. Acad. Sci, USA 
1996, 93:362-67; Brejc et al., Proc. Nat. Acad. Sci, USA 
1997, 94:2306-11; Cubitt et al., Trends in Biochem. Sci. 
1995, 20:448-55; Kain & Kitts, Methods Mo!. Biol. 1997, 
63:305-24) and DsRed (Gross et al., Proc. Natl. Acad. Sci., 
USA 2000, 97:11990-11995; Jakobs et al., FEBS Lett. 2000, 
479:131-135; Wall et al; Nat. Struct. Biol. 2000, 7:1133-
1138; Yarbrough et al., Proc. Natl. Acad. Sci., USA 2001, 
98:462-467) are excellent in vivo labels, and have been 
observed on the single molecule level in in vitro studies by 65 
many authors (Dickson et al., Nature 1997, 388:355-358; 
Malvezzi-Campeggi et al., Biophys. J. 2001, 81:1776-1785; 
55 probes, created with greatly improved photostability, much 
stronger absorption and emission under weak illumination, 
facile synthesis and conjugation to proteins, and tunable 
emission color. Ideally, such fluorescent labels should also be 
genetically progranimable such that proteins under study can 
60 be directly labeled intracellularly, without first being over-
expressed, purified, labeled, and then reintroduced into cells. 
SUMMARY OF THE INVENTION 
It is an object of the present invention to overcome, or at 
least alleviate, one or more of the difficulties or deficiencies 
associated with the prior art. The present invention fulfills in 
US 7,611,907 B2 
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part the need to identify new, unique strongly fluorescent 
labels that allow for the facile study of molecules at either 
single molecule or bulk concentrations. The compositions 
comprise a water-soluble fluorescent label comprising an 
encapsulated noble metal nanocluster. In one embodiment, 
the noble metal nanocluster comprises between 2 and 8 noble 
metal atoms. In preferred embodiments, the noble metal is 
selected from the group consisting of gold, silver, and copper. 
In certain embodiments, the noble metal nanocluster has a 
varying charge. 
Preferably, the fluorescent label exhibits a polarized spec-
tral emission and exhibits a dipole emission pattern. The 
fluorescent label has a spectral emission that provides infor-
mation about a biological state, wherein the biological state is 
selected from the group consisting of a quantitative and quali-
tative presence of a biological moiety; structure, composition, 
and conformation of a biological moiety; localization of a 
biological moiety in an environment; an interaction between 
biological moieties, an alteration in structure of a biological 
compound, and an alteration in a cellular process. 
6 
The present invention further encompasses methods of 
using the fluorescent labels described herein in order to study 
a biological state. The invention provides for a method of 
monitoring a molecule of interest comprising: a) attaching a 
water-soluble fluorescent label comprising an encapsulated 
noble metal nanocluster to a molecule of interest, wherein the 
fluorescent label emits an emission spectrum over a certain 
range of visible or near infrared wavelengths; and b) detecting 
the emission spectrum of the fluorescent label. In certain 
10 embodiments, the method further comprises the initial step of 
attaching a linker molecule to the encapsulated noble metal 
nanocluster, wherein the linker molecule is capable of attach-
ing the fluorescent label to the molecule of interest. In a 
preferred embodiment, the molecule of interest is present in a 
15 biological sample. In one preferred embodiment, the noble 
metal nanocluster is encapsulated in a peptide. Preferably, the 
peptide is expressed in a cell. In one embodiment, the peptide 
comprises a fusion polypeptide. 
20 BRIEF DESCRIPTION OF THE DRAWINGS 
Preferably the fluorescent label of the present invention is 
capable of fluorescing over a pH range of approximately 3 to 
approximately 8, and the noble metal nanocluster emits 
greater than approximately 106 photons, greater than 107 , 
greater than 108 , or greater than 109 photons before pho- 25 
tobleaching. In one embodiment, the encapsulated noble 
metal nanocluster has a fluorescence quantum yield of greater 
than approximately 1 % and a saturation intensity ranging 
from approximately 1 to 1000 W/cm2 at a nanocluster spectral 
30 
FIG. lA provides UV-Visible absorption spectra of aque-
ous silver/dendrimer solutions. (1) indicates strong plasmon 
absorption (398 nm) characteristic of large, non-fluorescent 
dendrimer-encapsulated silver nanoparticles prepared 
through NaBH4 reduction of silver ions in the dendrimer host 
(1: 12 dendrimer:Ag). (2) indicates the absorption spectrum 
of unreduced, non-fluorescent 1:3 ( dendrimer:Ag) solution 
before photoactivation, and (3) indicates the same solution 
after photoactivation/photoreduction to produce highly fluo-
rescent silver nanodots. FIG. lB provides electrospray ion-
ization mass spectrum of photoactivated G2-0H PAMAM 
(MW: 3272 amu)-AgN03 solution. Agn nanodot peaks are 
spaced by theAg atomic mass (107 .8 amu) and only appear in 
excitation maximum. 
In certain preferred embodiments, the noble metal nano-
cluster is encapsulated in a dendrimer. In one embodiment, 
the dendrimer comprises poly(amidoamine), wherein the 
poly( amidoamine) dendrimer is selected from the group con-
sisting of a 0th generation, 1st generation, 2nd generation, 3rd 
generation, a 4th generation, and a higher generation poly 
(amidoamine) dendrimer. In another embodiment, the poly 
(amidoamine) dendrimer is a rd generation, or a 4th genera-
tion OH-terminated poly(amidoamine) dendrimer. 
35 the fluorescent, photoactivated nanodot solutions. 
FIGS. 2A-D show mercury lamp excited (450 to 480 nm, 
30 W/cm2 , scale bar=15 µm) epifluorescence microscopy 
images demonstrating time-dependent photoactivation of 
aqueous dendrimer-encapsulated silver nanodots. Each 300 
40 ms CCD frame shows increasing fluorescence with illumina-
tion time at 0 seconds, 0.3 seconds, 1.5 seconds, and 6 sec-
onds. FIG. 2E shows surface-bound silver nanodot emission 
patterns in aqueous solutions. Indicative of single molecules, 
In certain other preferred embodiments, the noble metal 
nanocluster is encapsulated in a peptide. Preferably the pep-
tide is from approximately 5-500 amino acids in length. In 
other embodiments, the peptide is from approximately 5-20 
amino acids in length. In a further embodiment, the peptide 45 
comprises a polypeptide sequence as defined in SEQ ID 
NO:l. 
the anisotropic emission patterns and fluorescence blinking 
are easily observable under weak Hg lamp excitation. 
FIG. 3 shows room temperature single nanodot confocal 
fluorescence spectra ( 476-nm Ar+ laser excitation, 496-nm 
long-pass filter, dispersed by a 300-mm monochrometer). 
Emission maxima for the five typical nanodots shown are 533 
The present invention provides a method of preparing a 
dendrimer encapsulated noble metal nanocluster capable of 
fluorescing as described herein, comprising the steps of: a) 
combining a dendrimer, an aqueous solution comprising a 
noble metal, and an aqueous solvent to create a combined 
solution; b) adding a reducing agent; c) adding a sufficient 
amount of an acidic compound to adjust the combined solu-
tion to a neutral range or physiological pH; and d) mixing the 
pH adjusted, combined solution to allow the formation of a 
dendrimer encapsulated noble metal nanocluster. The inven-
tion further provides a method of preparing a peptide encap-
sulated noble metal nanocluster capable of fluorescing as 
described herein, comprising the steps of a) combining a 
peptide, an aqueous solution comprising a noble metal, and 
an aqueous solution to create a combined solution; b) adding 
a reducing agent; c) adding a sufficient amount of an acidic 
compound to adjust the combined solution to a neutral range 
pH; and d) mixing the pH adjusted, combined solution to 
allow the formation of the peptide encapsulated noble metal 
nanocluster. 
50 nm, 553 nm, 589 nm, 611 nm, and 648 nm. The ensemble 
fluorescence spectrum of bulk silver nanodot solutions (top) 
largely consists of these five spectral types, which are indis-
tinguishable from that onAgO surfaces. 
FIG. 4A shows a single nanodot fluorescence lifetime and 
55 SB shows saturation intensity measurements of typical den-
drimer-encapsulated nanodots. In SA, 400-nm excited life-
times are limited by the 300 ps instrument response, but 
indicate a sub-100 ps component (92%) and a 1.6 ns compo-
nent (8%) after deconvolution. In 4B, saturation occurs 
60 at -400 W/cm2 (using off resonant, 514.5-nm excitation), 
with total intensity differences arising from variations in 
quantum yields among various nanodots. The organic dye, 
DiIC18, for comparison, has a saturation intensity of 10 
kW/cm2 . Comparisons to DiI yield a lower estimate of the 
65 fluorescence quantum yield of-30%. 
FIG. SA shows UV-Vis absorption spectra of aqueous gold 
nanodot and pure dendrimer solutions. FIG. SB shows sub-
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traction of absorption spectra in A revealing the 384-nm 
absorption of PAMAM encapsulated Au nanodots. 
FIG. 6 shows excitation and emission spectra of G4-0H 
PAMAM encapsulated gold nanoclusters at room tempera-
ture. The excitation spectrum is denoted by "1", while the 
emission spectrum is denoted with "2." 
8 
amino acids in length. In a further embodiment, the peptide 
comprises a polypeptide sequence as defined in SEQ ID 
NO:l. 
FIG. 7A shows lifetime measurement of gold nanodots in 
aqueous solution. Instrumental response and nanodot data 
with fit exhibit the 7.5 ns (93%) and 2.8 µs (7%) lifetimes. 
FIG. 7B shows ESI mass spectrum of G2-0H PAMAM 10 
encapsulated gold nanodots with expected m/z of 4940 for 
G2-0H+Au8 +5H2 0+H+. 
The present invention provides a method for preparing a 
dendrimer encapsulated noble metal nanocluster, comprising 
the steps of: a) combining a dendrimer, an aqueous solution 
comprising a noble metal, and an aqueous solvent to create a 
combined solution; b) adding a reducing agent; c) adding a 
sufficient amount of an acidic compound to adjust the com-
bined solution to a neutral range or physiological pH; and d) 
mixing the pH adjusted, combined solution to allow the for-
mation of a dendrimer encapsulated noble metal nanocluster. 
The invention further provides a method of preparing a pep-
tide encapsulated noble metal nanocluster capable of fluo-
rescing, comprising the steps of a) combining a peptide, an 
aqueous solution comprising a noble metal, and an aqueous 
FIG. 8 shows the excitation and emission spectra of 
PAMAM dendrimer encapsulated copper nanoclusters at 
room temperature. The excitation spectrum is denoted by "1 ", 15 
while the emission spectrum is denoted with "2." 
solution to create a combined solution; b) adding a reducing 
agent; c) adding a sufficient amount of an acidic compound to 
adjust the combined solution to a neutral range or physiologi-DETAILED DESCRIPTION OF THE INVENTION 
The present invention provides compositions comprising a 
fluorescent label, methods for preparing the compositions 
and methods of using the compositions. The compositions of 
the present invention comprise encapsulated noble metal 
nanoclusters which are capable of fluorescing. The fluores-
cent labels provide certain advantages over known fluores-
cent labels, which include the small size, much stronger 
absorption and emission under weak illumination, facile syn-
thesis and conjugation to proteins, tunable emission color, 
and the option to genetically program the labels such that 
proteins can be directly labeled intracellularly. 
The present invention provides for compositions compris-
ing a water-soluble fluorescent label comprising an encapsu-
lated noble metal nanocluster. In one embodiment, the noble 
metal nanocluster comprises between 2 and 8 noble metal 
atoms. In preferred embodiments, the noble metal is selected 
from the group consisting of gold, silver, and copper. 
In one embodiment, the fluorescent label exhibits a polar-
ized spectral emission and/or a dipole emission pattern. The 
fluorescent label has a spectral emission that provides infor-
mation about a biological state, wherein the biological state is 
selected from the group consisting of a quantitative and quali-
tative presence of a biological moiety; location, structure, 
composition, and conformation of a biological moiety; local-
ization of a biological moiety in an environment; an interac-
tion between biological moieties, an alteration in structure of 
a biological compound, and an alteration in a cellular process. 
Preferably the fluorescent label of the present invention is 
capable of fluorescing over a pH range of approximately 3 to 
approximately 8, and the noble metal nanocluster emits 
greater than approximately 106 photons before photo bleach-
ing. In a further embodiment, the noble metal nanocluster 
emits greater than approximately 10 7 , 108 , or greater than 109 
photons before photobleaching. 
In certain preferred embodiments, the noble metal nano-
cluster is encapsulated in a dendrimer. In one embodiment, 
the dendrimer comprises poly(amidoamine), wherein the 
poly( amidoamine) dendrimer is selected from the group con-
sisting of a oth generation, 1st generation, rd generation, 3rd 
generation, a 4th generation, and a higher generation poly 
(amidoamine) dendrimer. In another embodiment, the poly 
(amidoamine) dendrimer is a rd generation, or a 4th genera-
tion OH-terminated poly(amidoamine) dendrimer. 
In certain other preferred embodiments, the noble metal 
nanocluster is encapsulated in a peptide. Preferably the pep-
tide is from approximately 5-500 amino acids in length. In 
other embodiments, the peptide is from approximately 5-20 
20 cal pH; and d) mixing the pH adjusted, combined solution to 
allow the formation of the peptide encapsulated noble metal 
nanocluster. 
The present invention further encompasses methods of 
using the fluorescent labels in order to study a biological state. 
25 The invention provides for a method of monitoring a mol-
ecule of interest comprising: a) attaching a water-soluble 
fluorescent label comprising an encapsulated noble metal 
nanocluster to a molecule of interest, wherein the fluorescent 
label emits an emission spectrum over a certain range of 
30 visible and near infrared wavelengths; and b) detecting the 
emission spectrum of the fluorescent label. In certain embodi-
ments, the method further comprises the initial step of attach-
ing a linker molecule to the encapsulated noble metal nano-
cluster, wherein the linker molecule is capable of attaching 
35 the fluorescent label to the molecule of interest. In a preferred 
embodiment, the molecule of interest is present in a biologi-
cal sample. In one preferred embodiment, the noble metal 
nanocluster is encapsulated in a peptide. Preferably, the pep-
tide is expressed in a cell. In one embodiment, the peptide 
40 comprises a fusion polypeptide. 
The highly fluorescent water-soluble noble metal nano-
clusters (nanodots) described herein are easily observed as 
single nanodots with weak mercury lamp excitation due to 
their incredibly strong absorption and emission (Peyser et al., 
45 Science 2001, 291:103; Peyser et al., J. Phys. Chem. B 2002, 
106:7725). With absorption strengths comparable to those of 
much larger quantum dots, these highly fluorescent and 
incredibly photostable nanodots are useful, in one embodi-
ment, as single molecule and bulk fluorescent biolabels. The 
50 creation of stable, biocompatible individual noble metal 
nanoclusters greatly facilitates the use of these photoactivated 
nanomaterials as extremely small, bright fluorophores. Such 
bright, easily synthesized, robustnanomaterials of the present 
invention will expand the accessibility of single molecule 
55 methods by greatly decreasing experimental cost and com-
plexity and providing optically excited fluorophores capable 
of producing orders of magnitude more photons from indi-
vidual molecules than currently possible. 
One aspect of the invention described herein provides the 
60 production and characterization of extremely robust, incred-
ibly bright, photoactivated biological labels that are simulta-
neously very small, biocompatible, suitable for specific in 
vitro and in vivo labeling and easily observed on the single 
molecule level with only weak mercury lamp excitation. At 
65 least 20 times brighter than the best organic dyes, the bright-
ness and ease of synthesis enables researchers to easily per-
form single molecule experiments with standard, inexpen-
US 7,611,907 B2 
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sive, lamp-based fluorescence microscopes. As described 
herein, only a few atoms to few tens of atoms of a noble metal 
are necessary to generate extremely bright compounds easily 
observed on the single molecule level. As a result, the proper 
biocompatible scaffold (generally a dendrimer, genetically 
optimized peptide, or any other appropriate encapsulating 
material) encapsulating the noble metal nanoclusters makes 
these very useful and potentially the smallest possible in vivo 
and in vitro labels. 
10 
tially or fully throughout the dendrimer, or attached or linked 
to the dendrimer or any combination thereof, whereby the 
attachment or linkage is by means of covalent bonding, 
hydrogen bonding, adsorption, absorption, metallic bonding, 
van der Waals forces or ionic bonding, or any combination 
thereof. Since the size, shape and functional group density of 
the dendrimers can be rigorously controlled by well-known 
methods, there are many ways in which the carried material 
(i.e. the noble metal nanoclusters) can be associated with the 
Unless otherwise noted, the terms used herein are to be 
understood according to conventional usage by those of ordi-
nary skill in the relevant art. In addition to the definitions of 
terms provided below, definitions of common terms in 
molecular biology may also be found in Rieger et al., 1991 
Glossary of genetics: classical and molecular, 5th Ed., Berlin: 
10 dendrimer. For example, (a) there can be covalent, coulom-
bic, hydrophobic, or chelation type association between the 
carried material(s) and entities, typically functional groups, 
located at or near the surface of the dendrimer; (b) there can 
be covalent, coulombic, hydrophobic, or chelation type asso-
Springer-Verlag; and in Current Protocols in Molecular Biol-
ogy, F. M. Ausubel et al., Eds., Current Protocols, a joint 
venture between Greene Publishing Associates, Inc. and John 
Wiley & Sons, Inc., (1998 Supplement). It is to be understood 
that as used in the specification and in the claims, "a" or "an" 
can mean one or more, depending upon the context in which 
it is used. Thus, for example, reference to "a cell" can mean 
that at least one cell can be utilized. 
15 ciation between the carried material(s) and moieties located 
within the interior of the dendrimer; ( c) the dendrimer can be 
prepared to have an interior which is predominantly hollow 
allowing for entrapment (e.g., physically within or by asso-
ciation with the interior moieties of the dense star dendrimer) 
20 of the carried materials within the interior (void volume), 
(e.g., magnetic or paramagnetic cores or domains created by 
the chelation and complete or incomplete reduction of metal 
ions to the zero or non-zero valence state within the den-
The present invention may be understood more readily by 
reference to the following detailed description of the pre- 25 
ferred embodiments of the invention and the Examples 
included herein. However, before the present compounds, 
compositions, and methods are disclosed and described, it is 
to be understood that this invention is not limited to specific 
noble metals, specific polypeptides, specific dendrimers, spe- 30 
cific conditions, or specific methods, etc., as such may, of 
course, vary, and the numerous modifications and variations 
therein will be apparent to those skilled in the art. It is also to 
be understood that the terminology used herein is for the 
purpose of describing specific embodiments only and is not 35 
intended to be limiting. 
drimer), these dendrimers containing magnetic interiors can 
be used for harvesting various bioactive entities that can be 
complexed with various dendrimer surfaces by use of mag-
nets and the like, wherein the release of the carried material 
can optionally be controlled by congesting the surface of the 
dendrimer with diffusion controlling moieties; or ( d) various 
combinations of the aforementioned phenomena can be 
employed. 
As used herein, the term "noble metal" refers to the group 
of elements selected from the group consisting of gold, silver, 
and copper and the platinum group metals (PGM) platinum, 
palladium, osmium, iridium, ruthenium and rhodium. In cer-
tain preferred embodiments of the present invention, the 
noble metal is selected from the group consisting of gold, 
silver, and copper. In other preferred embodiments, the noble 
metal is silver. In other preferred embodiments, the noble 
metal is gold. In other preferred embodiments, the noble 
metal is copper. 
As used herein, the term "nanocluster" refers to an asso-
ciation of 2-27 atoms of a metal. Manufactured nanoclusters 
are known and are becoming increasingly important in the 
fields of catalysis, ceramics, semiconductors, and materials 
science, among others. Their importance is due to the high 
ratio of surface atoms to interior atoms in nanoclusters. This 
imparts properties such as high surface reactivities, increased 
hardness and yield, strength, decreased ductility, liquid-like 
behavior at low temperature, and size-related chemical, 
physical, and/or quantum effects that are distinct from those 
properties of their macro-scale counterparts. At its finest divi-
sion, an element consists of a single atom. Molecules consist 
of simple aggregates of a few atoms, and metals and other 
As used herein, "encapsulating material" refers to a sub-
strate which is capable of attaching to, or physically associ-
ating with one or molecules of a noble metal nanocluster. An 
encapsulating material can provide a means for attaching the 40 
noble metal nanocluster indirectly to a molecule of interest, 
and can protect the noble metal nanocluster from the environ-
ment. The attachment or linkage is by means of covalent 
bonding, hydrogen bonding, adsorption, absorption, metallic 
bonding, van der Waals forces or ionic bonding, or any com- 45 
bination thereof. As used herein, "encapsulated" means that 
one or more molecules of the noble metal nanocluster can be 
physically associated with or entrapped within the encapsu-
lating material, dispersed partially or fully throughout the 
encapsulating material, or attached or linked to the encapsu- 50 
lating material or any combination thereof, whereby the 
attachment or linkage is by means of covalent bonding, 
hydrogen bonding, adsorption, absorption, metallic bonding, 
van der Waals forces or ionic bonding, or any combination 
thereof. 55 macrocrystalline solids comprise a crystalline or polycrystal-
line lattice extending outwards in continuous, three dimen-
sional arrays of atoms. The dimensions of atoms and mol-
ecules are measured in angstroms, one angstrom being 10-10 
m or 0.1 nanometers. Crystalline domains in microcrystalline 
The noble metal nanoclusters encompassed by the present 
invention can be encapsulated by any suitable encapsulating 
material, which includes, but is not limited to, a dendrimer, a 
polypeptide, a surfactant, and a non-dendrimer polymer. In 
one embodiment, the dendrimer is a PAMAM dendrimer. In 
another embodiment, the polypeptide comprises a sequence 
ranging form 5-500 amino acids in length. In another embodi-
ment, the polypeptide comprises an antibody. 
As used herein with respect to a dendrimer, for example, 
"encapsulated" means that the one or more molecules of the 
noble metal nanocluster can be physically associated with or 
entrapped within the core of the dendrimer, dispersed par-
60 solids such as metals typically are measured on the scale of 
micrometers. Nanoclusters occupy the transition from the 
simple atomic state to the nanocrystalline state and may have 
diameters in the range of about 0.1 to about 3 nm. Preferably, 
the nanoclusters as described herein comprise approximately 
65 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 
21, 22, 23, 24, 25, 26, or 27 atoms. In other preferred embodi-
ments, the nanoclusters comprise approximately 2-27 atoms, 
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approximately 2-25 atoms, approximately 2-20 atoms, 
approximately 2-15 atoms, approximately 2-10 atoms, or 
approximately 2-8 atoms. The size of the nanocluster pre-
ferred for encapsulation in an encapsulating material such as 
a dendrimer or peptide can depend on the type of metal used, 
the desired emission color, and the particular application. 
As used herein, a "nanoparticle" is defined as a particle 
having a diameter of from approximately 3 to approximately 
100 nanometers, having any size, shape or morphology, and 
comprising a noble metal as defined herein. 
12 
intensity can vary depending at least on the size of the nano-
cluster, and the metal comprising the nanocluster, and can be 
readily determined by one of ordinary skill in the art using 
methods well known in the art. While the fluorescent label as 
described herein is capable of fluorescing at a low excitation 
energy such as by a weak mercury lamp, in one embodiment 
the fluorescent label can fluoresce when activated by a laser. 
The spectral emission can be determined for the fluores-
cent labels of the present invention. Atoms and collections of 
10 atoms (or molecules) can make transitions between the elec-
tronic energy levels allowed by quantum mechanics by 
absorbing or emitting the energy difference between the lev-
els. The wavelength of the emitted or absorbed light is such 
As used herein, a "nanodot" is a noble metal nanocluster 
that is encapsulated in an encapsulating material, such as a 
dendrimer or a peptide, wherein the encapsulated noble metal 
nanocluster is capable of fluorescing at a low excitation inten-
sity. Preferably, the encapsulated noble metal nanocluster has 15 
a fluorescence quantum yield of greater than approximately 
that the photon carries the energy difference between the two 
orbits. This energy may be calculated by dividing the product 
of the Planck constant and the speed oflight he by the wave-
1 % and has a saturation intensity ranging from approximately 
1 to 1000 W/cm2 at a nanocluster excitation maximum. In 
certain embodiments, the fluorescence quantum yield is 
greater than approximately 2%, 3%, 4%, 5%, 10%, 15%, 
20%, 25%, 30%, 35%, 40%, 45%, 50%, 60% or higher. In 
certain embodiments, the saturation intensity ranges from 
approximately 1-1000 W/cm2 , from approximately 10-800 
W/cm2 , or from approximately 10-500 W/cm2 . The excita-
tion maximum varies between nanoclusters, and is dependent 
at least on the type of metal atom, and the number of metal 
atoms in the nanocluster. The excitation maximum for a nano-
cluster is readily determined by one of ordinary skill in the art 
using means that are well known in the art. 
As used herein, the term "saturation intensity" refers to the 
intensity at which the absorption of the molecule saturates 
and is no longer linear with respect to excitation intensity. At 
the saturation intensity for the non-linear absorption of a 
molecule, multiphoton absorption is no longer dependent on 
the intensity raised to the power of the nonlinear interaction. 
The quantum yield is defined as the ratio of the number of 
photons emitted to the number of photons absorbed. 
As used herein, the term "water-soluble" refers to the abil-
ity to dissolve and/or form a suspension in an aqueous solu-
tion. While the fluorescent label may visibly dissolve in an 
aqueous solution, it is at least temporarily dispersible or 
capable of forming a suspension in an aqueous solution. 
As used herein, the term "fluorescence" or "fluorescent" is 
length of the light. Thus, an atom or collection of atoms can 
absorb or emit only certain wavelengths (or equivalently, 
frequencies or energies) as dictated by the detailed atomic 
20 structure of the atoms. When the corresponding light is 
passed through a prism or spectrograph it is separated spa-
tially according to wavelength. The corresponding spectrum 
may exhibit a continuum, or may have superposed on the 
continuum bright lines (an emission spectrum). Thus, emis-
25 sion spectra are produced when the atoms do not experience 
many collisions (because of the low density). The emission 
lines correspond to photons that are emitted when excited 
states in the molecule or collection of atoms make transitions 
back to lower-lying levels. In a preferred embodiment of the 
30 present invention, the spectral emission of the fluorescent 
label is polarized. In other embodiments, depending on nano-
cluster properties, the emission may exhibit different degrees 
of polarization. In certain embodiments, the encapsulated 
noble metal nanocluster exhibits a dipole emission pattern. 
35 Preferably, the spectral emission characteristics of the fluo-
rescent label are at least partially determined by one or more 
characteristics selected from the group consisting of: the 
encapsulating material used, the generation of the dendrimer, 
the pH of the test environment, the pH of the environment in 
40 which the nanodot is formed, the affinity of the peptide forthe 
noble metal nanocluster which is determined by the peptide 
sequence, the size of the nanocluster, and the specific noble 
metal used to form the encapsulated noble metal nanocluster. 
Preferably the noble metal nanocluster has a varying 
45 charge. As used herein, the term "varying charge" refers to the 
fact that a noble metal nanocluster can be completely or 
incompletely reduced, or can be negatively charged. In cer-
tain applications, a noble metal nanocluster of a certain 
charge may be preferred. The charge of a noble metal nano-
a physical phenomenon based upon the ability of certain 
molecules to absorb and emit light at different wavelengths. 
The absorption of light (photons) at a first wavelength is 
followed by the emission of photons at a second wavelength 
and different energy. As used herein, a "fluorescent label" is a 
molecule which absorbs light at a first wavelength and emits 
the photons at a second wavelength and different energy. As 
used herein, a "fluorescent label" is used interchangeably 
with a "luminescent label," and "fluorescent" and "fluores-
cence" are used interchangeably with the terms "lumines-
cent" and "luminescence," respectively. As such, fluores-
cence is meant to include phosphorescence and Raman 
emission, and all emissions indicated by the term "lumines-
cence." As used herein, the term "saturated fluorescence" 
refers to the ability of a molecule to fluoresce at all incident 
intensities. Preferably, the fluorescent label comprises an 
encapsulated noble metal nanocluster. Preferably, the fluo-
rescent labels of the present invention fluoresce at a low 
excitation intensity, such as that provided by a mercury lamp. 
Preferably, the low excitation intensity is approximately 30 
W/cm2 at approximately 460 nm. In other embodiments, the 
excitation intensity can range from <1 W/cm2 up to 10 65 
kW/cm2 at a range of excitation wavelengths from approxi-
mately 330 nm to approximately 900 nm. The excitation 
50 cluster is readily determined by one of ordinary skill in the art 
using well-known methods. 
The noble metal nanoclusters of the present invention are 
preferably less than 3 nm in diameter, and can be smaller than 
2 nm or 1 nm in diameter. After encapsulation, the encapsu-
55 lated noble metal nanoclusters can range in diameter from 
less than 1 nm to approximately or greater than 15 nm. The 
size of the encapsulated noble metal nanocluster is largely 
dependent on the encapsulating material used. For example, 
in one embodiment, an antibody such as IgG is used to encap-
60 sulate the noble metal nanocluster. These antibodies are 
approximately 10 nm in diameter. Large 10-50 nm encapsu-
lated noble metal nanoclusters can be filtered by the lym-
phatic system in vivo for imaging purposes. 
As used herein, a "dendritic polymer" is a polymer exhib-
iting regular dendritic branching, formed by the sequential or 
generational addition of branched layers to or from a core. 
The term dendritic polymer encompasses "dendrimers," 
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which are characterized by a core, at least one interior 
branched layer, and a surface branched layer. (See Dvomic & 
Tomalia in Chem. in Britain, 641-645,August 1994.)A "den-
dron" is a species of dendrimer having branches emanating 
from a focal point which is or can be joined to a core, either 
directly or through a linking moiety to form a dendrimer. 
Many dendrimers comprise two or more dendrons joined to a 
common core. However, the term dendrimer is used broadly 
to encompass a single dendron. In the present invention, a 
preferred dendrimer is a poly(amidoamine) or PAMAM den-
drimer, however, the use of other dendrimers is contemplated. 
Preferably the dendrimer is selected from the group consist-
ing of a oth generation, a 1st generation, a rd generation, a 3rd 
generation, a 4th generation or greater generation dendrimer. 
The dendrimer can have any termination, including, but not 
limited to a OH terminating, COOH terminating, and NH2 
terminating. The generation of the dendrimer selected varies 
depending on the desired specific application for the encap-
sulated noble metal nanocluster. 
Dendritic polymers include, but are not limited to, sym-
metrical and unsymmetrical branching dendrimers, cascade 
molecules, arborols, and the like, though the most preferred 
dendritic polymers are dense star polymers. The PAMAM 
dendrimers disclosed herein are symmetric, in that the branch 
arms are of equal length. The branching occurs at the hydro-
gen atoms of a terminal -NH2 group on a preceding genera-
tion branch. 
14 
cyanate end of the bi-functional cross-linker, N-(p-maleimi-
dophenyl)isocyanate, leaving a thiol-reactive maleimide for 
coupling to proteins. 
As used herein, the term "photobleaching" comprises all 
processes, which result in the reduction of the intensity of 
fluorescent light generated at the wavelength of excitation. In 
embodiments of the present invention, the noble metal nano-
cluster emits greater than approximately 106 , 107 , or 108 
photons before photo bleaching. In a more preferred embodi-
1 o ment, the noble metal nanocluster emits greater than approxi-
mately 109 photons before photo bleaching. Photo bleaching is 
readily assessed by one of ordinary skill in the art. 
In certain preferred embodiments of the present invention, 
when the encapsulated noble metal nanoclusters are excited, 
15 greater than approximately 80% of the noble metal nanoclus-
ters fluoresce for greater than approximately 30 minutes. 
Preferably, the noble metal nanoclusters fluoresce at a con-
tinuous excitation energy of approximately 300 W/cm2 at 
514.5 nm or 476 nm. In another embodiment, preferably 
20 greater than approximately 90% of the noble metal nanoclus-
ters fluoresce for greater than approximately 30 minutes. In 
other embodiments, greater than 80%, or greater than 90% of 
the nanoclusters have a fluorescence quantum yield of greater 
than approximately 1 % and a saturation intensity that ranges 
25 from 1-1000 W/cm2 with emission continuing for greater 
than 30 minutes. 
In one embodiment, a dendrimer encapsulated noble metal 
Even though not formed by regular sequential addition of 
branched layers, hyperbranched polymers, e.g., hyper-
branched polyols, may be equivalent to a dendritic polymer 30 
where the branching pattern exhibits a degree of regularity 
approaching that of a dendrimer. 
nanocluster is used to deliver noble metal nanoclusters across 
biological membranes to a peptide that strongly binds the 
noble metal nanocluster. The strength of binding to the noble 
metal nanocluster is readily determined by one of ordinary 
skill in the art, and can include a visual estimation of the 
intensity of the fluorescence. In a preferred embodiment, the 
dendrimer is a lower generation dendrimer, such as a oth Topological polymers, with size and shape controlled domains, are dendrimers that are associated with each other 
(as an example covalently bridged or through other associa-
tion as defined hereafter) through their reactive terminal 
groups, which are referred to as "bridged dendrimers." When 
more than two dense star dendrimers are associated together, 
they are referred to as "aggregates" or "dense star aggre-
gates." 
Therefore, dendritic polymers include bridged dendrimers 
and dendrimer aggregates. Dendritic polymers encompass 
both generationally monodisperse and generationally poly-
disperse solutions of dendrimers. The dendrimers in a mono-
disperse solution are substantially all of the same generation, 
and hence of uniform size and shape. The dendrimers in a 
polydisperse solution comprise a distribution of different 
generation dendrimers. 
35 generation, 1st generation, or 2nd generation. In other embodi-
ments, the dendrimer is a higher generation dendrimer, such 
as a 3rd or 4th or higher generation dendrimer. In certain 
embodiments, the peptide binds the noble metal nanocluster 
at a range of pH. Preferably, the peptide stably binds the noble 
40 metal nanocluster at a pH range of between 10 and 1, more 
preferably between 9 and 2, more preferably between 8 and 3. 
In other embodiments the peptide stably binds the noble 
metal nanocluster at a pH of 9, 8, 7, 6, 5, 4, or 3. This 
embodiment will allow for the facile labeling of proteins both 
45 in vitro and in vivo. 
Dendritic polymers also encompass surface modified den- 50 
drimers. For example, the surface of a PAMAM dendrimer 
may be modified by the addition of an amino acid (e.g., lysine 
The terms "polynucleotide," "oligonucleotide," "nucleic 
acid" and "nucleic acid molecule" are used herein to include 
a polymeric form of nucleotides of any length, either ribo-
nucleotides or deoxyribonucleotides. This term refers only to 
the primary structure of the molecule; thus, the term includes 
triple-, double- and single-stranded DNA, as well as triple-, 
double- and single-stranded RNA. It also includes modifica-
tions, such as by methylation and/or by capping, and unmodi-
fied forms of the polynucleotide. More particularly, the terms 
or arginine). 
As used herein, the term "generation" when referring to a 
dendrimer means the number oflayers of repeating units that 
are added to the initiator core of the dendrimer. For example, 
a 1st generation dendrimer comprises an initiator core and one 
layer of the repeating unit, and a 2nd generation dendrimer 
comprises an initiator core and two layers of the repeating 
unit, etc. Sequential building of generations (i.e., generation 
number and the size and nature of the repeating units) deter-
mines the dimensions of the dendrimers and the nature of 
their interior. 
Methods for linking dendrimers to biological substrates are 
well known to those of skill in the art, and include the use of 
linker molecules. For example, thiol-reactive species can be 
made by coupling the dendrimer hydroxyl group to the iso-
55 "polynucleotide," "oligonucleotide," "nucleic acid" and 
"nucleic acid molecule" include polydeoxyribonucleotides 
(containing 2-deoxy-D-ribose ), polyribonucleotides (con-
taining D-ribose ), any other type of polynucleotide which is 
an N- or C-glycoside ofa purine or pyrimidine base, and other 
60 polymers contammg non-nucleotidic backbones, for 
example, polyamide (e.g., peptide nucleic acids (PNAs)) and 
polymorpholino (commercially available from the Anti-Vi-
rals, Inc., Corvallis, Oreg., as Neugene) polymers, and other 
synthetic sequence-specific nucleic acid polymers providing 
65 that the polymers contain nucleobases in a configuration 
which allows for base pairing and base stacking, such as is 
found in DNA and RNA. There is no intended distinction in 
US 7,611,907 B2 
15 
length between the terms "polynucleotide," "oligonucle-
otide," "nucleic acid" and "nucleic acid molecule," and these 
terms will be used interchangeably. These terms refer only to 
the primary structure of the molecule. Thus, these terms 
include, for example, 3'-deoxy-2', 5'-DNA, oligodeoxyribo-
nucleotide N3' PS' phosphoramidates, 2'-0-alkyl-substituted 
RNA, double- and single-stranded DNA, as well as double-
and single-stranded RNA, DNA:RNA hybrids, and hybrids 
between PNAs and DNA or RNA, and also include known 
types of modifications, for example, labels which are known 10 
in the art, methylation, "caps," substitution of one or more of 
the naturally occurring nucleotides with an analog, inter-
nucleotide modifications such as, for example, those with 
uncharged linkages (e.g., methyl phosphonates, phosphotri-
esters, phosphoramidates, carbamates, etc.), with negatively 15 
charged linkages (e.g., phosphorothioates, phosphorodithio-
ates, etc.), and with positively charged linkages (e.g., ami-
noalklyphosphoramidates, aminoalkylphosphotriesters), 
those containing pendant moieties, such as, for example, pro-
teins (including nucleases, toxins, antibodies, signal pep- 20 
tides, poly-L-lysine, etc.), those with intercalators (e.g., acri-
dine, psoralen, etc.), those containing chelators (e.g., metals, 
radioactive metals, boron, oxidative metals, etc.), those con-
taining alky la tors, those with modified linkages (e.g., alpha 
anomeric nucleic acids, etc.), as well as unmodified forms of 25 
the polynucleotide or oligonucleotide. In particular, DNA is 
deoxyribonucleic acid. 
These terms also encompass untranslated sequence located 
at both the 3' and 5' ends of the coding region of the gene: at 
least about 1000 nucleotides of sequence upstream from the 5' 30 
end of the coding region and at least about 200 nucleotides of 
sequence downstream from the 3' end of the coding region of 
the gene. Less common bases, such as inosine, 5-methylcy-
tosine, 6-methyladenine, hypoxanthine and others can also be 
used for antisense, dsRNA and ribozyme pairing. For 35 
example, polynucleotides that contain C-5 propyne ana-
logues ofuridine and cytidine have been shown to bind RNA 
with high affinity and to be potent anti sense inhibitors of gene 
expression. Other modifications, such as modification to the 
phosphodiester backbone, or the 2'-hydroxy in the ribose 40 
sugar group of the RNA can also be made. The antisense 
polynucleotides and ribozymes can consist entirely of ribo-
nucleotides, or can contain mixed ribonucleotides and deox-
yribonucleotides. The polynucleotides of the invention may 
be produced by any means, including genomic preparations, 45 
cDNA preparations, in vitro synthesis, RT-PCR, and in vitro 
or in vivo transcription. 
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vitro nucleic acid preparation or as a transfected/transformed 
host cell preparation, wherein the host cells are either an in 
vitro heterogeneous preparation or plated as a heterogeneous 
population of single colonies. Also specifically excluded are 
the above libraries wherein a specified nucleic acid makes up 
less than 5% of the numberof nucleic acid inserts in the vector 
molecules. Further specifically excluded are whole cell 
genomic DNA or whole cell RNA preparations (including 
whole cell preparations that are mechanically sheared or 
enzymatically digested). Even further specifically excluded 
are the whole cell preparations found as either an in vitro 
preparation or as a heterogeneous mixture separated by elec-
trophoresis wherein the nucleic acid of the invention has not 
further been separated from the heterologous nucleic acids in 
the electrophoresis medium (e.g., further separating by excis-
ing a single band from a heterogeneous band population in an 
agarose gel or nylon blot). 
In one preferred embodiment, an isolated nucleic acid 
encoding a peptide that binds a noble metal nanocluster is 
introduced into a cell, and the peptide is expressed and binds 
the noble metal nanocluster. In certain embodiments, isolated 
nucleic acids encoding a peptide that binds the noble metal 
nanocluster can also be chimeric or fusion polynucleotides. 
As used herein, a "chimeric polynucleotide" or "fusion poly-
nucleotide" comprises a nucleic acid encoding a peptide that 
binds the noble metal nanocluster operably linked to a second 
nucleic acid sequence. Preferably, the second nucleic acid 
sequence does not bind or does not strongly bind the noble 
metal nanocluster, and has both a different polynucleotide 
sequence and encodes a protein having a different function 
than a nucleic acid encoding a peptide that binds the noble 
metal nanocluster. Within the fusion polynucleotide, the term 
"operably linked" is intended to indicate that the nucleic acid 
encoding a peptide that binds the noble metal nanocluster and 
the second nucleic acid sequence, respectively, are fused to 
each other so that both sequences fulfill the proposed function 
attributed to the sequence used. The second nucleic acid 
sequence can be fused to the N-terminus or C-terminus of the 
nucleic acid encoding a peptide that binds the noble metal 
nanocluster. 
Procedures for introducing a nucleic acid into a cell are 
well known to those of ordinary skill in the art, and include, 
without limitation, transfection, transformation or transduc-
tion, electroporation, particle bombardment, agroinfection, 
and the like. In certain embodiments, the nucleic acid is 
incorporated into a vector or expression cassette that is then 
introduced into the cell. Other suitable methods for introduc-
ing nucleic acids into host cells can be found in Sambrook, et 
An "isolated" nucleic acid molecule is one that is substan-
tially separated from other nucleic acid molecules that are 
present in the natural source of the nucleic acid (i.e., 
sequences encoding other polypeptides). Preferably, an "iso-
lated" nucleic acid is free of some of the sequences that 
naturally flank the nucleic acid (i.e., sequences located at the 
5' and 3' ends of the nucleic acid) in its naturally occurring 
replicon. For example, a cloned nucleic acid is considered 
isolated. A nucleic acid is also considered isolated if it has 
been altered by human intervention, or placed in a locus or 
location that is not its natural site, or if it is introduced into a 
cell by transfection. Moreover, an "isolated" nucleic acid 
molecule can be free from some of the other cellular material 
with which it is naturally associated, or culture medium when 
produced by recombinant techniques, or chemical precursors 
50 al., Molecular Cloning: A Laboratory Manual. 2nd Ed., Cold 
Spring Harbor Laboratory, Cold Spring Harbor Laboratory 
Press, Cold Spring Harbor, N.Y., 1989, and other laboratory 
manuals such as Methods in Molecular Biology, 1995, Vol. 
44, Agrobacterium protocols, Ed: Gartland and Davey, 
or other chemicals when chemically synthesized. 
Specifically excluded from the definition of "isolated 
nucleic acids" are: naturally-occurring chromosomes (such 
as chromosome spreads), artificial chromosome libraries, 
genomic libraries, and cDNA libraries that exist either as an in 
55 Humana Press, Totowa, N.J. 
As used herein, the term polypeptide refers to a chain of at 
least four amino acids joined by peptide bonds. The chain 
may be linear, branched, circular or combinations thereof. 
The terms "peptide," "polypeptide," and "protein" are used 
60 interchangeably herein. The terms do not refer to a specific 
length of the product. Thus, "peptides," "oligopeptides," and 
"proteins" are included within the definition of polypeptide. 
The terms include post-translational modifications of the 
polypeptide, for example, glycosylations, acetylations, phos-
65 phorylations and the like. In addition, protein fragments, ana-
logs, mutated or variant proteins, fusion proteins and the like 
are included within the meaning of polypeptide. 
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The invention also provides chimeric or fusion polypep-
tides. As used herein, an "chimeric polypeptide" or "fusion 
polypeptide" comprises an polypeptide which binds a noble 
metal nanocluster operatively linked to a second polypeptide. 
Preferably the second polypeptide has an amino acid 
sequence that is not substantially identical to a noble metal 
nanocluster optimized binding polypeptide, e.g., a polypep-
tide which does not stably bind a noble metal nanocluster as 
described herein. As used herein with respect to the fusion 
polypeptide, the term "operatively linked" is intended to in di- 1 o 
cate that the two polypeptides are fused to each other so that 
both sequences fulfill the proposed function attributed to the 
sequence used. The second polypeptide can be fused to the 
N-terminus or C-terminus of the polypeptide which binds a 
noble metal nanocluster. Such fusion polypeptides can facili- 15 
tate the single molecule or bulk studies and allow for the 
direct labeling of peptides in vivo or in vitro. 
In certain embodiments of the present invention, the pep-
tide which binds the noble metal nanocluster is from approxi-
mately 5-1000 amino acids in length, from 1-800 amino acids 20 
in length, or from 5-500 amino acids in length. In certain 
embodiments, the peptide is from approximately 5-10 amino 
acids in length. In other embodiments, the peptide is from 
approximately 10-20 or from 20-40 amino acids in length. In 
one embodiment, the peptide comprises a polypeptide 25 
sequence as defined in SEQ ID NO: 1. 
The present invention further encompasses methods for the 
preparation of the encapsulated noble metal nanoclusters 
having the characteristics as described herein. In one embodi-
ment, the method of preparing a dendrimer encapsulated 30 
noble metal nanocluster comprises the steps of: a) combining 
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CuS04 .nH2 0. In one embodiment, the aqueous solution 
comprising a noble metal is AgN03 . In another embodiment, 
the aqueous solution comprising a noble metal is 
HAuC14 .nH20. In a further embodiment, the aqueous solu-
tion comprising a noble metal is CuS04 .nH20. 
In one embodiment, the aqueous solution comprising a 
noble metal is HAuC14 .nH2 0, a reducing agent is added to the 
combined solution, and the pH adjusted, combined solution is 
mixed for at least one hour to allow the formation of the 
dendrimer encapsulated gold nanocluster. In another embodi-
ment, the pH adjusted, combined solution is mixed for about 
48 hours to allow the formation of a dendrimer encapsulated 
goldnanocluster. In another embodiment, encapsulated noble 
metal nanoclusters are created through photoreduction 
through irradiation with visible or ultraviolet light to allow 
the formation of a dendrimer encapsulated gold, silver or 
copper nanocluster. 
In another embodiment, when the encapsulating material is 
a peptide, preferably the noble metal to peptide molar ratio in 
step a) is approximately 0.1:1. In another embodiment, the 
noble metal to peptide molar ratio in step a) is less than 
approximately 0.1:1, and in other embodiments it is greater 
than 0.1: 1, and can be 1: 1 or greater. 
In certain embodiments, the encapsulated noble metal 
nanocluster fluorescent labels is present in a biological 
sample. In certain preferred embodiments, the peptide which 
encapsulates the noble metal nanocluster is expressed within 
a cell, also termed "genetically programmed." As used herein, 
the term "expressed" encompasses the transcription and/or 
the translation of the peptide. In other embodiments, the 
peptide encapsulating the noble metal nanocluster is intro-
duced into a biological sample. As used herein, a "biological 
sample" refers to a sample of isolated cells, tissue or fluid, 
including but not limited to, for example, plasma, serum, 
spinal fluid, semen, lymph fluid, the external sections of the 
skin, respiratory, intestinal, and genitourinary tracts, tears, 
saliva, milk, blood cells, tumors, organs, and also samples of 
in vitro cell culture constituents (including, but not limited to, 
conditioned medium resulting from the growth of cells in cell 
a dendrimer, an aqueous solution comprising a noble metal, 
and an aqueous solvent to create a combined solution; b) 
adding a reducing agent; c) subsequently adding a sufficient 
amount of an acidic compound to adjust the combined solu- 35 
tion to a neutral range pH; and d) mixing the pH adjusted, 
combined solution to allow the formation of a dendrimer 
encapsulated noble metal nanocluster. In a second embodi-
ment, the method of preparing a peptide encapsulated noble 
metal nanocluster capable of fluorescing comprises the steps 40 culture medium, putatively virally infected cells, recombi-
nant cells, and cell components). The fluorescent labels can 
be used in a cell from any type of organism, wherein the 
organism is a prokaryote or a eukaryote. In preferred embodi-
ments of the present invention, the organism is a eukaryote. 
of: a) combining a peptide, an aqueous solution comprising a 
noble metal, and distilled water to create a combined solution; 
b) adding a reducing agent; c) subsequently adding a suffi-
cient amount of an acidic compound to adjust the combined 
solution to a neutral range pH; and d) mixing the pH adjusted, 
combined solution to allow the formation of the peptide 
encapsulated noble metal nanocluster. 
In these methods, a reducing agent is added to the com-
bined solution to photoactivate the noble metal nanoclusters. 
Preferably the reducing agent is selected from the group 
comprising a chemical reducing agent, light, or a combina-
tion thereof. In certain embodiments of these methods, light 
can be used as a reducing agent to photoactivate the noble 
metal nanoclusters. In certain other embodiments of these 
methods, a chemical reducing agent can be used as a reducing 
agent. In one embodiment, light is used in combination with 
a reducing agent to photoactivate the noble metal nanoclus-
ters. Preferably the process of preparing the encapsulated 
noble metal nanoclusters is performed at a temperature of 
between approximately 65° F. to approximately 100° F. More 
preferably, the temperature of the combined solution from 
steps a) through c) is between approximately 68° F. to 
approximately 80° F., and even more preferably between 
approximately 68° F. to approximately 74° F. 
Preferably, the aqueous solution comprising a noble metal 
used in the preparation of the compounds is selected from the 
group consisting of AgN03 , HAuC14 .nH20, and 
45 Non-limiting examples of the eukaryotic cells of the present 
invention include cells from animals, plants, fungi, protists, 
and other microorganisms. In certain embodiments, the cells 
are part of a multicellular organism, e.g., a plant or animal. 
As discussed herein, the selection of the composition of the 
50 encapsulated nanocluster, as well as the size of the dendrimer 
or the sequence of the peptide, affects the characteristic spec-
tral emission wavelength of the semiconductor nanocrystal. 
Thus, as one of ordinary skill in the art will realize, a particu-
lar composition of a nanodot as described herein will be 
55 selected based upon the spectral region being monitored. For 
example, nanodots that emit energy in the visible range, or in 
the red, blue or near-IR range can be designed. In one embodi-
ment, the encapsulated noble metal nanocluster displays 
increasingly higher energy emission with decreasing nano-
60 cluster size. 
The water-soluble encapsulated noble metal nanoclusters 
of the present invention find use in a variety of assays where 
other, less reliable, labeling methods have typically been 
used, including, without limitation, fluorescence microscopy, 
65 histology, cytology, pathology, flow cytometry, FISH and 
other nucleic acid hybridization assays, signal amplification 
assays, DNA and protein sequencing, immunoassays such as 
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compet1t1ve binding assays and ELISAs, immunohis-
tochemical analysis, protein and nucleic acid separation, 
homogeneous assays, multiplexing, high throughput screen-
ing, chromosome karyotyping, and the like. The above-de-
scribed encapsulated noble metal nanocluster fluorescent 
labels can be used in any reporter molecule-based assay with 
an acceptable environment. 
20 
Molecular Cloning, Second Edition, Cold Spring Harbor 
Laboratory, Plainview, N.Y.; Maniatis et al., 1982 Molecular 
Cloning, Cold Spring Harbor Laboratory, Plainview, N.Y.; 
Wu (ed.) 1993 Meth. Enzymol. 218, Part I; Wu (ed.) 1979 
Meth Enzymol. 68; Wu et al., (Eds.) 1983 Meth. Enzymol. 
100and101; Grossman& Moldave (Eds.) 1980 Meth. Enzy-
mol. 65; Miller (ed.) 1972 Experiments in Molecular Genet-
ics, Cold Spring Harbor Laboratory, Cold Spring Harbor, 
N.Y.; Old and Primrose, 1981 Principles of Gene Manipula-
In certain preferred embodiments, the encapsulated noble 
metal nanocluster fluorescent label of the present invention is 
used in single or bulk molecule studies. The invention encom-
passes methods of monitoring a molecule of interest compris-
ing: a) attaching a water-soluble fluorescent label comprising 
10 tion, University of California Press, Berkeley; Schleif & 
Wensink, 1982 Practical Methods in Molecular Biology; 
Glover (ed.) 1985 DNA Cloning Vol. I and II, IRL Press, 
Oxford, UK; Hames &Higgins (eds.) 1985 Nucleic Acid 
Hybridization, IRL Press, Oxford, UK; and Setlow & Hol-
an encapsulated noble metal nanocluster to a molecule of 
interest, wherein the fluorescent label emits an emission spec-
trum; and b) detecting the emission spectrum of the fluores-
cent label. As used herein, detecting the emission spectrum 
encompasses determining the optical emission properties of 
the fluorescent label. Single molecule studies can allow for 
the determination of aspects of the local environment, rang-
ing from signal strength, orientation, and lifetime, to the 20 
emission spectrum of the molecule and the degree of energy 
transfer with neighboring molecules. Single molecule studies 
have been used to manipulate individual molecules and to 
measure the force generated by molecular motors or covalent 
bonds. The development of new probe technologies allows 25 
for real-time observations of molecular interactions and traf-
ficking within living cells. These tools enable individual 
members of a population to be examined, identified, and 
quantitatively compared within cellular sub-populations and 
substructures. Single molecule studies have the potential to 
provide spatial and temporal information that is impossible to 
obtain using other, more static techniques. Single molecule 
studies allow for measurements to be made on the in vivo 
dynamic movements of single molecules in intracellular 
space or to observe the behavior of single molecules over 35 
extended periods of time. Using single molecule methods, it 
should be possible to study time trajectories and reaction 
pathways of individual members in a cellular assembly with-
out averaging across populations. Cellular processes, such as 
exocytosis, flux through channels, or the assembly of tran-
scription complexes, could be visualized. Individual differ-
ences in structure or function generated by allelic polymor-
phisms should be detectable at the level of the single 
molecule. Additionally, monitoring the coordinated expres-
sion of a gene or group of genes in specific tissues, or at 45 
certain developmental stages, can be performed using these 
technologies. As such, the use of an encapsulated noble metal 
nanocluster fluorescent probe allows for the determination of 
15 laender 1979 Genetic Engineering: Principles and Methods, 
Vols. 1-4, Plenum Press, New York. Abbreviations and 
nomenclature, where employed, are deemed standard in the 
field and commonly used in professional journals such as 
those cited herein. 
Throughout this application, various publications are ref-
erenced. The disclosures of all of these publications and those 
references cited within those publications in their entireties 
are hereby incorporated by reference into this application in 
order to more fully describe the state of the art to which this 
invention pertains. The following examples are not intended 
to limit the scope of the claims to the invention, but are rather 
intended to be exemplary of certain embodiments. Any varia-
tions in the exemplified methods that occur to the skilled 
artisan are intended to fall within the scope of the present 
30 invention. 
EXAMPLES 
Example 1 
Generation of Dendrite-Encapsulated Silver 
Nanoclusters 
40 Methods 
a spectral emission that provides information about a biologi-
cal state. As used herein, the term "biological state" refers to 50 
making a determination of condition such as a quantitative 
and qualitative presence of a biological moiety; structure, 
composition, and conformation of a biological moiety; local-
ization of a biological moiety in an environment; an interac-
tion between biological moieties, an alteration in structure of 55 
a biological compound, and an alteration in a cellular process. 
The methods and compositions of the present invention can 
further comprise the use of a linker molecule wherein the 
linker molecule is capable of attaching the fluorescent label 
comprising an encapsulated noble metal nanocluster to a 60 
molecule of interest. 
PAMAM is known to sequester metal ions from solution 
(Crooks et al., Accounts Chem. Res. 2001, 34: 181; Ottaviani 
et al., Macromolecules 2002, 35:5105; Zheng et al., J. Phys. 
Chem. B 2002, 106:1252; Vamavski et al., J. Chem. Phys. 
2001, 114:1962). PAMAM G4-0H and G2-0H dendrimers 
(4'h and rd-generation OH-terminated poly(amidoamine), 
respectively, Aldrich) were therefore utilized to concentrate, 
stabilize, and solubilize Ag nanoclusters in both aerated and 
deaerated aqueous solutions. By dissolving 0.5 µmo! G4-0H 
and 1.5 µmo! AgN03 into 1 ml distilled water (18 MQ) and 
adjusting the solution to neutrality with 160 µmo! acetic acid, 
silver ions readily interact with the dendrimer. Usually used 
to create small nanoparticles (>3 nm diameter), literature 
preparations generally add small amounts of reducing agents 
such as NaBH4 (Crooks et al., Accounts Chem. Res. 2001, 
34:181; Ottaviani et al., Macromolecules 2002, 35:5105; 
Zheng et al., J. Phys. Chem. B 2002, 106:1252; Vamavski et 
al., J. Chem. Phys. 2001, 114: 1962). In order to create den-
drimer-encapsulated nanoclusters ("nanodots"), not nanopar-
ticles, reducing agents were not added to the reactions. The 
fluorescence of these solutions was probed by placing a 10-ml 
drop of the solution on a clean coverslip in ambient air, 
nitrogen, and/or evacuated (10-5 torr) environments which 
was then irradiated with blue light (450-480 nm) from a 
Standard techniques for cloning, DNA isolation, amplifi-
cation and purification, for enzymatic reactions involving 
DNA ligase, DNA polymerase, restriction endonucleases and 
the like, and various separation techniques are those known 
and commonly employed by those skilled in the art. A number 
of standard techniques are described in Sambrook et al., 1989 
65 bandpass-filtered mercury lamp through a standard epifluo-
rescence microscope. Results were unaffected by degree of 
oxygenation or dendrimer generation. 
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Results 
Initially, no visible absorption or fluorescence was 
observed from these solutions, but, photoactivation was 
clearly demonstrated by the solution absorption spectra (FIG. 
lA) before and after exposure to white light. Initially only the 
dendrimer contributed to the spectrum with a single absorp-
tion at 284 nm. After photoactivation, the solution exhibited 
two new peaks at 345 nm and 430 nm due to the absorption of 
small, photoreduced silver nanodots (Ag2 -Ag8) (Rabin et al., 
G. Chem. Phys. Lett. 1999, 312:394; Bonacic'-Koutecky et 
al., J. Chem. Phys. 2001, 115:10450). The size and geometry 
differences of the small silver nanodots simultaneously cre-
ated during photoactivation yielded multicolored fluores-
cence throughout the visible region. Silver nanoclusters of 
this size are the only ones known to have strong visible 
absorption and emission (Rabin et al., G. Chem. Phys. Lett. 
1999, 312:394; Bonacic'-Koutecky et al., J. Chem. Phys. 
2001, 115:10450; Linnert et al., J. Am. Chem. Soc. 1990, 
112:4657; Mostafavi et al., Chem. Phys. Lett. 1990, 167: 
193). The small size was confirmed by mass spectrometry of 
photoactivated fluorescent nanodot solutions (FIG. lB). 
Borohydride-reduced solutions yielded larger silver nanopar-
ticles (3-7 nm) with a characteristic strong surface plasmon 
absorption at 398 nm, but with essentially no fluorescence 
(FIG. lA). Thus, since the fluorescent silver nanodots only 
appeared without the plasmon absorption, they must be much 
smaller than 3 nm, and are likely smaller than 2 nm. 
Correlating with the changes in absorption, fluorescence 
grew with increasing irradiation time as silver ions were 
photoreduced inside the dendrimer host. Within -6 seconds, 
the field of view was filled with individual blinking fluores-
cent species, with little subsequent photoactivation (FIGS. 
2A-D). These very bright, stable fluorescent features were all 
highly polarized and exhibited well-defined dipole emission 
patterns (FIG. 2E; Bartko & Dickson, J. Phys. Chem. B 1999, 
103:11237) and blinking dynamics (Lu et al., Science 1998, 
282: 1877; Dickson et al., Nature 1997, 388:355; Hu et al., J. 
Am. Chem. Soc. 1999, 121:6936) characteristic ofindividual 
emitters. After completion of photoactivation in this silver-
limited environment, the fluorescent silver-dendrimer nan-
odots remained very stable both in average emission intensity 
and in spectral characteristics. The dendrimer thereby stabi-
lized the nanoclusters and enhanced their optical properties 
relative to those on AgO films (Peyser et al., Science 2001, 
291:103; Peyser et al., J. Phys. Chem. B 2002, 106:7725). 
Because the binding energy of small Ag nanoclusters is less 
than the excitation energy, the cage effect of the dendrimer 
likely acts similarly to that ofrare gas matrices (Rabin et al., 
Chem. Phys. Lett. 1999, 312:394) to stabilize and enhance 
nanocluster fluorescence by preventing photodissociation. 
While water is known to quench Ag nanocluster fluorescence 
on AgO films (Mihalcea et al., J. Am. Chem. Soc. 2001, 
123:7172), dendrimer-encapsulated silver nanodots were 
highly fluorescent and quite stable in water solution. Thus, the 
photochemically produced Ag nanoclusters were also pro-
tected inside the dendrimer, thereby preventing interaction 
with quenchers in solution. 
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Contrary to studying nanoclusters onAgO films (Peyser et 
al., Science 2001, 291:103; Peyser et al., J. Phys. Chem. B 
2002, 106:7725), single nanocluster spectroscopy was 
readily performed on these soluble dendrimer-encapsulated 
silver nanodots. While the bulk spectra of Agn onAgO and of 
the aqueous nanodot solutions (FIG. 3) was indistinguish-
able, individual Ag nanodots had much narrower and more 
stable emission spectra than either bulk nanodot samples or 
individual nanoclusters onAgO films (FIG. 3). Because nano-
10 cluster size on AgO films was continually modified with 
excitation, individual nanoclusters were observed to exhibit 
large spectral shifts (Peyser et al., Science 2001, 291: 103; 
Peyser et al., J. Phys. Chem. B 2002, 106:7725). In contrast, 
five stable and easily distinguished fluorescence spectra were 
15 obtained from these highly dispersed dendrimer-encapsu-
lated silver nanodots (FIG. 3), suggesting that the bulk spec-
trum was dominated by as few as five nanocluster sizes. 
Considerably narrower than those of bulk nanodot films or 
solutions, room temperature single nanodot fluorescence 
20 spectra exhibited no obvious spectral diffusion. Because no 
additional silver could be incorporated into the nanodot and 
the dendrimer stabilized the nanodot fluorescence, single 
nanodot emission was quite stable and robust with maxima at 
533 nm, 553 nm, 589 nm, 611 nm and 648 nm, although 
25 fluorescence intermittency was readily observed. In compari-
son to II-VI nanoparticles, these nanodots were very photo-
stable with -80% of individual features remaining fluores-
cent for >30 minutes of continuous 514.5 nm or 476 nm 
excitation at 300 W/cm2 . The nanodot photoactivation, blink-
30 ing, dipole emission patterns, spectral stability, mass spec-
trometry, and fluorescence was observed only for small sized 
nanodots, further confirming that individual dendrimer-en-
capsulatedAgn nanoclusters less than 8 atoms in size gave rise 
to the observed emission. No fluorescence was observed in 
35 similarly prepared solutions without the dendrimer or solu-
tions prepared without the silver. Crucial to solubility and 
stabilization, the dendrimer enhouses and protects the nano-
clusters, yielding strong emission and providing a silver-
limited environment that prevents further photoreduction/ 
40 nanocluster growth. 
Through these methods, very photostable, water-soluble 
silver nanodots have been successfully created in dendrimers 
through direct photoreduction in ambient conditions. Such 
silver nanodots are quite stable and highly fluorescent both in 
45 aqueous solutions and in films and are readily observed on the 
single molecule level with weak mercury lamp excitation (30 
W/cm2 ). With synthetic control of dendrimer attachment (for 
example, thiol-reactive species can be made by coupling the 
dendrimer hydroxyl group to the isocyanate end of the bi-
50 functional cross-linker, N-(p-maleimidophenyl)isocyanate, 
leaving a thiol-reactive maleimide for coupling to proteins), 
such simple nanomaterials are likely to find use as biological 
labels, thereby making single molecule studies much more 
widely accessible without expensive laser sources. The 
55 intense photoactivated emission and very long life before 
photo bleaching makes these attractive new nanomaterials for 
studying chemical and biological systems. 
Electrospray ionization mass spectrometry (ESI-MS) of 
the photoactivated nanodot solutions showed strong enrich-
ment of dendrimer+Agn with n=2-4 over non-photoactivated, 60 
and thereforenon-fluorescentnanodot solutions (FIG. lB). In 
non-photoactivated nanodot solutions, the dendrimer+Ag2 
and larger nanocluster peaks were unobservable, clearly indi-
cating emission from dendrimer-encapsulated Ag nanoclus-
ters ranging in size from 2 to at most 8 atoms once the 65 
solutions are photoactivated (Zheng & Dickson, J. Am. 
Chem. Soc., 2002, 124:13982-13983). 
Example 2 
Characterization of Individual Ag Nanodots 
A range of PAMAM dendrimer generations (GO-OH 
through G4-0H with diameters (MW) ranging from 1.5 nm 
(517 g/mol) to 4.5 nm (14,215 g/mol) were used to yield 
highly fluorescent Agn nanodots. Very bright fluorescence 
was observed over a pH range of 8.0 to 3.0. These different 
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generations of PAMAM enabled a measure of control over 
nanocluster distributions: nanodots created with smaller den-
drimer generations exhibited different emission spectra than 
nanodots created with higher dendrimer generations. Not 
only was nanodot emission extremely stable in spectrum and 5 
intensity, but they also exhibited highly polarized emission 
with very clear and stable dipole emission patterns (FIG. 2E). 
The observation of emission patterns enabled to employment 
life before photobleaching makes these attractive new nano-
materials for studying biological systems. 
Example 3 
Generation of Dendrite-Encapsulated Gold 
Nanoclusters 
Previous studies have yielded fluorescent, surface passi-
vated gold nanoclusters ranging in size from 28 atoms to 
smaller particles ( <1.2 nm) with emission in the near IR (Link 
eta!., J. Phys. Chem. B 2002, 106:3410-3415), red (Huang & 
Murray, J. Phys. Chem. B 2001, 105:12498-12502), and blue 
(Wilcoxon et al., J. Chem. Phys.1998, 108:9137-9143), with 
of the three-dimensional orientational methods developed to 
follow orientational dynamics either in solution or of immo- 10 
bilized features, as described in Bartko, & Dickson, J. Phys. 
Chem. B 1999, 103:3053-3056; Bartko & Dickson, J. Phys. 
Chem. B 1999, 103:11237-11241; and Bartko et al., Chem. 
Phys. Lett. 2002, 358:459-465. 15 increasingly higher energy emission with decreasing nano-
cluster size. Although Au nanoclusters with million-fold 
enhanced fluorescence quantum yields cjlp, relative to that of 
bulk gold films (Mooradian, A. Phys. Rev. Lett. 1969, 22: 185-
187), have been created, the 10-3 to 10-4 quantum yields and 
The photophysical parameters of many of these individual 
Ag nanodots have also been characterized (FIG. 4A). While 
much smaller than quantum dots, the extremely bright nan-
odot fluorescence at low excitation intensities (30 W/cm2 at 
460 nm, close to the 450-nm excitation maximum) results 
from the very short fluorescence lifetime. After deconvolu-
tion of the instrument response, individual nanodot lifetimes 
exhibited a primary sub-100 ps component (92%) as mea-
sured with time-correlated single photon counting with 400-
nm excitation from a doubled Ti: sapphire laser. The nanodots 
also had a slower (1.6 ns) decay component. The very fast 
relaxation indicates a very strong connection between ground 
and excited states, thereby yielding a very strong transition 
moment from a very small (several atom) nanocluster. 
The absorption cross-section of individual nanodots was 
measured through saturation intensity measurements (FIG. 
4B). These were compared with well-characterized single 
DiIC18 molecules that have well-known saturation intensi-
ties, lifetimes, and fluorescence quantum yields (Macklin et 
al., Science 1996, 272:255-258). These experiments indicate 
that the Ag nanodots have absorption cross sections that are 
-20 times stronger than the best organic dyes and nearly 
identical to the best CdSe quantum dots. Additionally, 
through comparisons of total numbers of photons absorbed 
by single DiI molecules and single nanodots, the lower esti-
mates of the nanodot fluorescence quantum yields have been 
calculated to be at least -30%. Additionally, these Ag nan-
odots exhibited at least comparable photostability to much 
larger II-VI quantum dots, with >90% of individual features 
remaining fluorescent for >>30 minutes of continuous 514.5-
nm excitation at 300 W/cm2 . Generally lasting for more than 
an hour of continuous optical excitation while emitting > 106 
photons/sec near saturation, typical individual nanodots emit 
well over 109 photons before photobleaching. This is two 
orders of magnitude more total photons emitted than the best 
available dyes emit. Consequently these nanodots offer the 
opportunity to probe both the short time and long time single 
molecule dynamics within a wide range of biological sys-
tems. 
20 polydisperse nanoparticle size distributions have precluded 
them from being good fluorophores (Link et al., J. Phys. 
Chem. B 2002, 106:3410-3415; Huang & Murray, J. Phys. 
Chem. B 2001, 105:12498-12502). The present invention 
discloses water-soluble, monodisperse, blue-emitting Au8 
25 nanodots that when encapsulated in and stabilized by bio-
compatible PAMAM dendrimers (Tomalia, Sci. Am. 1995, 
272:62-66), exhibited a fluorescence quantum yield of 
41±5%, a more than 100-fold improvement over other 
reported gold nanoclusters (Link et al., J. Phys. Chem. B 
30 2002, 106:3410-3415; Huang & Murray, J. Phys. Chem. B 
2001, 105:12498-12502). Larger Aun nanodots have also 
been produced with strong luminescence throughout the vis-
ible region. 
Second and fourth generation OH-terminated PAMAM 
35 (G2-0H and G4-0H, respectively, Aldrich) were utilized to 
stabilize and solubilize gold nanoclusters in both aqueous and 
methanol solutions. By dissolving 0.5 µmo! G4-0H or 
G2-0H and 1.5 µmo! HAuCl4 .nH2 0 (Aldrich) into 2 mL of 
distilled water (18 MQ), gold ions were sequestered into 
40 dendrimers and reduced by slowly adding an equivalent of 
NaBH4 into the solution. Reduced gold atoms aggregated 
within the dendrimers to form small nanodots ( dendrimer-
encapsulated nanoclusters) and large nanoparticles. The solu-
tion was stirred for two days until reaction and aggregation 
45 processes were completed. Solutions were subsequently puri-
fied through centrifugation (13,000 g) to remove the large 
goldnanoparticles (Crooks et al., Accounts Chem. Res. 2001, 
34:181-190; Esumi et al., Langmuir 1998, 14:3157-3159), 
leaving a clear, colorless, gold nanodot solution. Although 
50 weak compared to the 285 nm pure dendrimerpeak (see FIG. 
SA), a clear absorption spectrum of dendrimer encapsulated 
gold nanoclusters was obtained by subtracting the pure den-
drimer absorption. It can be seen from FIG. SB that a new 
absorption band at 384 nm with bandwidth of -60 nm 
55 (FWHM) appeared in the final fluorescent Au nanodot solu-
tions. Contrary to the absorption spectrum oflarge gold nano-
particles, no surface plasmon absorption at 520 nm was 
observed from this solution, indicating that the nanodots are 
smaller than -2 nm (Crooks et al., Accounts Chem. Res. 
Thus, dendrimer-encapsulated water-soluble silver nano-
clusters (Ag nanodots) have been created through direct pho-
toreduction in ambient conditions. Such silver nanodots were 
quite stable in both solution and films and were readily 
observed on the single molecule level with weak mercury 
lamp excitation (30 W/cm2 ) when excited very close to the 
absorption maximum of 450 nm. With synthetic control of 
dendrimer attachment, such simple nanomaterials are very 
useful as biological labels, thereby making single molecule 65 
studies much more widely accessible without expensive laser 
sources. The intense photoactivated emission and very long 
60 2001, 34:181-190; Esumi et al., Langmuir 1998, 14:3157-
3159). 
Strong blue luminescence with excitation and emission 
maxima at 384 nm and 450 nm, respectively, was clearly 
observed from these dendrimer encapsulated gold nanodot 
solutions (FIG. 6). The fluorescence excitation maximum and 
bandwidth were identical to the nanodot absorption band in 
FIG. SB. While G2-0H and G4-0H dendrimers yielded 
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indistinguishable fluorescent solutions, under the same syn-
thetic conditions, GO dendrimers yielded only non-fluores-
cent solutions with black gold solids. These heterogeneous 
solutions suggest that, unlike larger rd and 4th generation 
PAMAM, small O'h generation dendrimers do not adequately 
protect and stabilize gold nanoclusters. Amazingly, for 384-
nm excitation, integrated fluorescence quantum yields for 
G4-0H and G2-0H encapsulated gold nanodots were 
26 
non-radiative relaxation pathways. Additionally, the larger 
dendrimer cage better protects these nanoclusters/nanodots 
from quenchers in solution. This latter interpretation is sug-
gested by the O'h generation dendrimer being unable to stabi-
lize fluorescent Au nanodots. Additionally, in the purified 
solutions there are no large gold nanoparticles to quench the 
nanodot fluorescence (Dulkeith et al., Phys. Rev. Lett. 2002, 
89, art. no.-203002; Huang & Murray, Langmuir 2002, 
18:7077-7081). 
In conclusion, monodisperse Aug nanodots were synthe-
sized and stabilized in dendrimer PAMAM aqueous solution. 
Aug nanodots show strong size specific emission, and its 
quantum yield was measured to be -41 % in aqueous solution. 
Practical applications of gold nanodots as a novel fluorophore 
41 %±5% using similarly emitting quinine sulfate as the ref-
erence. The quantum yield further increased in methanol to 10 
52%+5%. The time dependence of the emission showed that 
there are two lifetime components (FIG. 7 A), which are char-
acteristic of gold nanodot emission (Link et al., J. Phys. 
Chem. B 2002, 106:3410-3415). The short lifetime compo-
nent was 7 .5 ns, which was dominant (93%) in the emission 
and likely arose from singlet transitions between low lying d 
orbitals and excited sp bands of gold nanodots. The long 
lifetime component (2.8 µs, 7%) may be due to a triplet-
singlet intraband transition (Link et al., J. Phys. Chem. B 
2002, 106:3410-3415; Huang & Murray, J. Phys. Chem. B 20 
2001, 105:12498-12502). 
15 become possible due to more than 100-fold enhancement in 
quantum yield. 
The well-defined dendrimer structure enabled analysis of 
encapsulated nanocluster sizes with electrospray ionization 
(ESI) mass spectrometry. As shown in FIG. 7B, Aug was the 
dominant Au-containing component in the fluorescent solu- 25 
tions and its abundance directly correlates with fluorescence 
intensity, independent of sample preparation. Depending on 
the reduction conditions, Au concentrations, and dendrimer 
generations, different Au-containing peaks can appear in the 
mass spectra. In all cases (>20 differently prepared samples), 30 
blue fluorescence intensity was only related to the abundance 
of the Aug-containing species observed in the mass spectra. In 
accord with stable nanoclusters having 8 valence electrons 
(one from each Au atom; Lin et al., Inorg. Chem. 1991, 
30:91-95), this dominant nanocluster was confirmed to be in 35 
the overall neutral oxidation state as even 100-fold excess of 
highly reducing BH4 - did not alter the nanodot fluorescence. 
Confirmed through expected shifts relative to the dendrimer 
parent peak upon dissolution in D20 instead of H20, five 
molecules of water were also found to be associated with the 40 
hydrophilic PAMAM dendrimer-Au complex. While five 
waters appeared to be the favored number, smaller peaks 
corresponding to Aug with other numbers of water molecules 
ranging from one to six were also observed in the mass 
spectra of other similarly prepared samples. The peaks con- 45 
taining Aug were only observed in the fluorescent Au nanodot 
solutions and fluorescence intensities of differently prepared 
solutions were directly proportional to relative abundance of 
the Aug nano dot peaks alone. Additionally, Au nanodot prepa-
rations using both HAuCl4 andAuBr3 yielded indistinguish- 50 
able fluorescent solutions with identical mass spectra. This 
indicated that the highly efficient blue emission resulted from 
Aug nanodots. Different color emission can be produced by 
adjusting relative Au:dendrimer concentrations to produce 
larger Au nanodots. 55 
As mentioned above, luminescence from gold nanodots is 
thought to arise from transitions between the filled d band and 
sp conduction bands (Link et al., J. Phys. Chem. B 2002, 
106:3410-3415; Huang & Murray, J. Phys. Chem. B 2001, 
105: 12498-12502; Mohamed et al., Chem. Phys. Lett. 2000, 60 
317:517-523). As nanocluster size decreased, the spacings 
between discrete states in each band increased, leading to a 
blue shift in fluorescence relative to that from larger nano dots. 
The more than 100-fold fluorescence quantum yield enhance-
ment over that of differently prepared larger nanoclusters 65 
probably results from two factors. The lower density of states 
present in very small Aug nanoclusters minimizes internal 
Example 4 
Generation of Dendrite-Encapsulated Copper 
Nanoclusters 
Second and fourth generation OH-terminated PAMAM 
(G2-0H and G4-0H, respectively, Aldrich) were utilized to 
stabilize and solubilize copper nanoclusters in both aqueous 
and methanol solutions. By dissolving 0.5 µmo! G4-0H or 
G2-0H and 1.5 µmo! copper sulfate into 2 mL of distilled 
water (18 MQ), copper ions were sequestered into dendrim-
ers and reduced by slowly adding an equivalent ofN aBH4 into 
the solution. Reduced copper atoms aggregated within the 
dendrimers to form small nanodots ( dendrimer-encapsulated 
nanoclusters) and nanoparticles, leaving a clear, yellow, cop-
per nanodot solution. 
Strong blue luminescence with excitation and emission 
maxima at 392 nm and 470 nm, respectively, was clearly 
observed from these dendrimer encapsulated copper nanodot 
solutions (FIG. 8). The experiments are repeated with differ-
ent generations of PAMAM dendrimers, and the emission and 
excitation spectra determined. The quantum yields are deter-
mined for the different generation dendrimer encapsulated 
copper nanoclusters. The dendrimer structure allows analysis 
of the encapsulated nanocluster sizes with electrospray ion-
ization (ESI) mass spectrometry. Depending on the reduction 
conditions, copper concentrations, and dendrimer genera-
tions, different copper-containing peaks appear in the mass 
spectra. Further characterization of the dendrimer encapsu-
lated copper nanoclusters is performed as described in 
Examples 5-6 for dendrimer encapsulated silver nanodots. 
Example 5 
Optimizing and Controlling the Generation of 
Water-Soluble, Photoactivated, Fluorescent Ag 
Nanodots 
While dendrimers and chemical reducing agents are com-
monly employed for synthesis of large metal and semicon-
ducting nanoparticles, much smaller Ag nanodots are readily 
synthesized simply by adding a 0.5 mM aqueous AgN03 
solution to that of the desired PAMAM dendrimer in the 
proper molar ratios and adjusting to neutral pH. Generally, no 
chemical reductants are added, but similar results can be 
achieved by slowly adding small amounts of NaBH4 to cir-
cumvent photoactivation. In solutions without any added 
chemical reductants, no visible absorption and no fluores-
cence is observed in these mixtures as long as they are kept in 
the dark. However, after photoactivation of the entire solution 
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with an unfiltered 100 W Hg lamp for 5 minutes, both visible 
absorption near 450 nm and strong fluorescence appeared. 
Much faster photoactivation occurred within small volumes 
when the solutions were irradiated with higher intensity 
through the microscope. 
28 
doing this, a representative sample of individual nanodots is 
probed with the spectrometer to determine the number of 
differently emitting particles present in a given sample. Once 
spectral purity and narrowness of individual nanodot emis-
sion is confirmed, individual features is counted with a color 
CCD camera. A single-chip CCD with a standard mosaic 
filter to produce color images uses 4 pixels (one detecting red, 
one for blue, and two for green) to generate one composite 
color pixel. Small, diffraction limited features do not cover 
10 enough pixels to yield an accurate color on single chip color 
CCDs. When detected by such a camera, any small change in 
sample position will actually be registered as a color change 
in the emission due to detection by different numbers of red, 
blue and green pixels. Because of the small size of each 
While this nanodot synthetic process works very well, it 
produces a wide distribution of nanodots with fluorescence 
throughout the visible spectrum. In order to narrow the dis-
tribution of synthesized nanodots, spectral properties must be 
correlated with creation conditions. Certain nanocluster sizes 
are likely to be created preferentially under specific excitation 
and concentration conditions. For example, it was noted that 
total fluorescence intensity and overall emission color are 
strong functions of the dendrimer generation used: oth gen-
eration dendrimers formed primarily yellow and green highly 
fluorescent nanodots at low Ag:dendrimer ratios of 0.3:1, 
while 4th generation PAMAM required a much higher 
Ag:dendrimer ratio of 3: 1 and produced nanodots of all col-
ors. The reaction conditions are optimized by adjusting both 
Ag:dendrimer ratios and total concentrations in the reactions 20 
with oth through 4th or higher generation dendrimers. Work-
ing at ratios that only begin to produce fluorescence in each 
dendrimer generation, the concentration of the smallest emit-
ting nanoclusters will preferentially be enhanced. Aliquots 
from each solution are irradiated with different wavelength 25 
ranges for differing amounts of time. These solutions are 
compared with those obtained through sub-stoichiometri-
cally added NaBH4 solutions to compare chemical and pho-
toreduction processes. An aliquot of each sample solution is 
assayed by mass spectrometry using electrospray ionization 30 
and compared with the signal from a non-photoactivated 
solution. Parallel analyses with fluorescence microscopy and 
ES I-MS identify the spectral signatures of the smallest nano-
clusters. 
15 feature, a 3-chip CCD will give accurate color information. 
Using a three-chip CCD, the emission color of each particle 
will be identified and user-written particle counting software 
will be employed to automatically count the numbers of each 
color nanodot. The distribution of fluorescent colors from 
individual nanodots will be directly correlated with the mass 
spectrum of each photoactivated or chemically reduced solu-
tion to assign the colors to specific nanocluster sizes within 
each type of nanodot solution. The spectrometer will charac-
terize the spectral width of nanodot emission while the CCD 
only gives overall color, but with higher sensitivity and time 
resolution. Thus, the combination is important for accurately 
characterizing the individual nanodots and their distribution 
resulting from a given set of creation conditions. 
Example 6 
Optimizing the Synthesis of Specific Ag Nanodot 
Sizes 
The known pH sensitivity of PAMAM dendrimers andAg 
ions and atoms is used to control Ag nanocluster size and 
therefore control spectral properties. PAMAM is well-known 
to increase in size with decreasing pH (Kleinman et al., J. 
Phys. Chem. B 2000, 104:11472-11479; Lee et al., Macro-
molecules 2002 35:4510-4520; and Bosman et al., Chem. 
Rev. 1999 99: 1665-1688). This size change makes the den-
drimer exterior significantly more permeable and creates 
larger cavities to accommodate nanoclusters or even nano-
particles in their interiors. At high pH, the dendrimer is quite 
This set of experiments will help elucidate the distribution 35 
of Ag nanocluster sizes within the nanodot samples. Because 
the nanodots contain only a few atoms, nanodot sizes will 
likely at least loosely follow Poisson statistics (statistics of 
small numbers) giving predictable populations of silver 
atoms per dendrimer. Poisson statistics, however, assume that 40 
no other interactions are present to further bias the counting 
statistics. Because different nanoclusters will be more or less 
stable under different conditions, tuning nanodot creation 
conditions will yield a modified Poisson distribution, making 
experimental verification of relative populations critical to 
identifying the properties of each size nanodot. Adjusting the 
concentrations should alter the relative populations tempered 
45 compact, thereby preventing ions from reaching the den-
drimer core. This size behavior nicely complements the pref-
erence of silver for more basic environments. As a result, Ag 
ions and metal nanoclusters interact strongly with the basic 
amines on the dendrimer interior. As the pH decreases, the 
by the extent of reaction at a given concentration. The offset 
from Poisson statistics will be a direct measure of the relative 
equilibrium concentrations and any preferential stabilization 
of specific nanocluster sizes. Thus, changing concentrations 
of Ag for a given amount of dendrimer and assaying the 
mixtures both before and after photoactivation by mass spec-
trometry and fluorescence microscopy will yield detailed 
information on the equilibrium constants governing nanodot 
formation. These experiments will determine the necessary 
Ag concentrations to preferentially produce the desired silver 
nanocluster size within the nanodots and the equilibrium 
constants for each PAMAM generation. 
Additionally, the numbers of nanodots of a given color will 
be counted in the fluorescence microscope field of view using 
a color CCD camera and fluorescence spectrometer. Image 
simulation, fitting, and processing software has been written 
in IDL (Interactive Data Language, Research Systems, Inc.), 
an open shell programming environment that is ideal for 
image and mathematical processing. While measuring single 
molecule fluorescence spectra can be a tedious method of 
50 partitioning of Ag to the dendrimer interior should increase 
significantly. The increased dendrimer permeability and pref-
erence of Ag to interact with the dendrimer interior at acidic 
pH both suggest that larger nanoclusters should be more 
readily formed at low pH. Since pH has a more significant 
55 effect on higher dendrimer generations, the pH studies will be 
performed with 4th generation G4-0H and G4-NH2 PAMAM 
dendrimers. This scheme is used to preferentially shift nan-
odot size distributions to larger and smaller sizes. As a func-
tion of pH, bulk absorption and emission spectra are mea-
60 sured, and individual nanodots of a given color as described 
above are counted. Nanodot distribution is assayed as a func-
tion of both dendrimer generation and pH in order to gain 
control over nanodot spectral properties. Once the nanodots 
are created, pH will be returned to pH7 to assay stability of 
65 formed nanodots within the PAMAM host. ESI-MS is per-
formed on all such solutions to directly correlate changes in 
optical properties with changes inAg nanocluster sizes within 
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the nanodot samples. Together, these methods will enable 
determination of the spectral properties associated with spe-
cific Ag nanocluster sizes within the PAMAM dendrimers. 
Photophysical Characterization of Dendrimer-Encapsulated 
Nanodots. 
Bulk lifetime measurements are performed on the nan-
odots in the time domain utilizing a frequency doubled tita-
nium sapphire laser for excitation at 400 nm (82 MHz repeti-
tion rate, 200 fs pulse width), a 10 GHz Si photodiode, and a 
20 GSample/sec digital oscilloscope. In repetitive mode, this 
combination can sample points with 50 ps time resolution. 
This fast detection system is sensitive enough to work for bulk 
samples through the optical microscope, but, for individual 
nanodots, a time correlated single photon counting board 
(Picoquant) and relatively slow, but very sensitive avalanche 
photodiodes are used, which together are limited by APD 
jitter to lifetimes of -300 ps. With deconvolution of instru-
ment response, the primary fluorescence lifetime component 
of the Ag nanodots was determined to be -100 ps. Thus, the 
faster detection system is employed for facile measurement of 
sub-100 ps lifetimes on the relatively bright emission from 
groups of Ag nanodots. If multiple lifetimes are present, 
deconvoluting the different time components is quite straight-
forward with time-domain methods. 
30 
improved synthetic methodologies for preferentially enrich-
ing one nanodot size over others. 
Fluorescence Stability 
Largely unaffected by environmental interactions, the den-
drimer-stabilized emission is further explored to yield quan-
titatively similar emission for a given nanodot in a wide 
variety of different environs. Such environmental insensitiv-
ity is in stark contrast to that of II-VI (e.g. CdSe) quantum 
10 
dots in which surface passivation is crucial to overall photo-
physical properties due to the presence of trap states on the 
surface (Bruchez et al., Science 1998, 281:2013-2016; Chan 
& Nie, Science 1998 281:2016-2018; Nirmal et al., Nature 
1996 383:802-804; Huynh et al., Adv. Mater. 1999 11:923; 
15 
Alivisatos, Endeavour 1997, 21:56-60; Klimov et al., Phys. 
Rev. B 2000, 61:R13349-R13352). The dendrimer-encapsu-
lated nanodots appear to circumvent such difficulties by hav-
ing the chromophore ensconced within the water-soluble 
dendrimer core. The blinking (fluorescence intermittency) is 
20 
probed as a function of ionic strength and pH. Commonly 
used buffers such as phosphate buffers and sodium acetate/ 
acetic acid are used to simultaneously control pH while 
adjusting ionic strength. Quenchers ranging from acrylamide 
to dyes with different absorptions are added to each nanodot 
25 
solution to assay for energy transfer from the Ag nanodot. 
Absorption cross section measurements are made through 
comparison with single DiIC18 molecules, a dye with a very 
well-characterized absorption cross section and one that has 
been worked with on the single molecule level (Bartko, & 
Dickson, J. Phys. Chem. B 1999, 103:3053-3056; Bartko & 30 
Dickson, J. Phys. Chem. B 1999, 103:11237-11241; and Bar-
tko et al., Chem. Phys. Lett. 2002, 358:459-465). Confirming 
single molecule behavior through identifying blinking spe-
cies and those simultaneously exhibiting dipole emission pat-
terns allows for the circumvention of not knowing the exact 35 
concentration within a given sample, and simply measuring 
the strength of absorption relative to a single molecule of 
known absorption cross section and comparing the saturation 
intensities. Using the combination of individual nanodot 
spectra, their distributions within a given nanodot solution, 40 
and their corresponding absorption cross sections, the con-
centrations of each nanodot species is determined within a 
given sample. This will be useful in determining the optical 
density of a given color nanodot within a given solution and 
Stern-Volmer quenching studies are performed to determine 
the extent of quenching and, therefore, the influence of the 
dendrimer on the nanocluster stabilization and isolation from 
the environment. The fast lifetimes, however, suggest that 
these nanodots will be largely insensitive to quenching. In 
addition to blinking and total emission intensity, the fluores-
cence lifetime and spectra will also be measured to assay 
whether any changes occur due to environmental interac-
tions. With their very strong transitions and short lifetimes, 
however, they are likely to make excellent acceptors in FRET 
donor-acceptor pairs. Both bulk and single molecule experi-
ments decipher if any change in photophysical dynamics 
results from altered blinking dynamics or an average overall 
reduction in fluorescence efficiency. The host density and size 
of the dendrimers is also adjusted. Ag nanodot blinking 
dynamics and photophysical parameters in O'h through 4th 
generation PAMAM dendrimers are probed to directly deter-
mine the protection afforded by successively larger and 
higher density dendrimer hosts. These studies will directly 
assay the extent of penetration of solvent and quenchers into 
the dendrimer core. 
by using the initial concentrations of dendrimer and silver, the 45 
equilibrium constants for nanodot formation are determined. 
Using the measured concentrations of each size nanodot 
and its contribution to the total solution absorption, the opti-
cal density of a given nanodot type is determined. Through 
comparisons with methanolic rhodamine 6G solutions, nan-
odot solutions of the same optical density are prepared. Fluo-
rescence quantum yields are measured through exciting at a 
wavelength with nanodot optical density identical to that of 
one of the standard rhodamine solutions. The ratio of 
rhodamine fluorescence intensity to that of the desired nano-
cluster when looking within its characteristic spectral win-
dow (after accounting for the much smaller, but measured 
contributions from the other nanoclusters in solution) will 
directly yield the quantum yield of each nanodot. This ratio-
metric method enables accurate quantum yield measurements 
without having to know the absolute nanodot concentration 
because the number of photons absorbed is the same for both 
the rhodamine 6G reference and the nanodot being probed. 
Together, the mass spectrometry and photophysical charac-
terizations of both bulk and single molecule samples will 
definitively determine the sizes and photophysical signatures 
of each color of nanodots. This information will also lead to 
Orientational Dynamics 
The orientational dynamics oflinearly polarized individual 
surface bound nanodots are investigated for two reasons: 
50 geometry changes of small Ag nanoclusters are thought to 
result in very different absorption and emission wavelengths 
(Harbich et al., J. Chem. Phys. 1990, 93:8535-8543; Fedrigo 
et al., J. Chem. Phys. 1993, 99:5712-5717; Rabin et al., 
Chem. Phys. Lett. 2000, 320:59-64) and the orientational 
55 information may be very useful in biological labeling experi-
ments, whether used for energy transfer measurements or 
following the orientational motion of individual proteins. 
This is in contrast to the much larger CdSe quantum dots, 
which are not linearly polarized, but instead emit in all direc-
60 tions, being characterized by a unique "dark" axis (Empe-
docles et al., Nature 1999, 399:126-130). Thus, correlating 
orientational dynamics of the nanocluster with any observed 
spectral changes will be very important to understanding if 
geometry changes also give rise to differently colored Ag 
65 nanodots. These experiments will also be performed with the 
3-chip color CCD to obtain color emission patterns. In order 
to confirm that the spectrum is indeed narrow single nanodot 
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fluorescence spectra will be taken through the microscope 
coupled spectrograph using a 150 I/mm diffraction grating. 
The orientational trajectories are fit to the models of dipolar 
emission at an interface (Bartko et al., J. Phys. Chem. B 1999, 
103:3053-3056; Bartko & Dickson, J. Phys. Chem. B 1999, 5 
103:11237-11241; Hollars & Dunn, J. Chem. Phys. 2000, 
112:7822-7830; Hellen & Axelrod, J. Opt. Soc. Am. B-Opt. 
Phys. 1987, 4:337-350) as viewed through an optical micro-
scope to follow true 3-D nanocluster orientational dynamics 
resulting from any nanocluster mobility within the dendrimer 10 
hosts. 
Example 7 
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Example 8 
Identification of Optimal Peptides for Encapsulation 
of Silver Nanodots 
Because Ag is biocompatible and can be non-toxic, it pro-
vides unique opportunities for simultaneously developing the 
smallest and brightest possible in vivo fluorescent biolabels. 
These same methods can be applied to gold and copper nan-
odot formation within peptide scaffolds. Dendrimer-encap-
sulated nanodots can already be employed as small, 
extremely bright biocompatible labels. Although much 
smaller than GFP, the 3.272 kD rd generation PAMAM 
Peptide Encapsulation of Silver Nanodots 
Attempting to utilize the vast diversity inherent in biologi-
15 dendrimer is still larger than most organic dyes. To further 
explore the potential of using Ag nanodots as biological 
labels, specific peptide sequences are identified that can spe-
cifically bind to differently sized metal nanoclusters and their 
true prospects for specific multicolor labeling of biomol-
cal systems (Whaley et al., Nature 2000, 405:665-668; Lee et 
al., Science 2002, 296, 892-5; and Seeman & Belcher, 2002 
Proc. Nat. Acad. Sci., USA, 99 Suppl 2:6451-5), it was dem-
onstrated that a short 9-amino acid peptide can stabilize Agn 
nanocluster fluorescence. A short peptide having the 
sequence AHHAHHAAD (SEQ ID NO: 1) was recently 
reported to interact with large metal and semiconductor nano-
particles upon NaBH4 reduction (Djalali et al., J. Am. Chem. 
Soc. 2002 124:13660-13661; Slocik et al., Nano Lett. 2002 
2:169-173). Using the gentle photoactivation procedures 
described herein, very highly fluorescent peptide-encapsu-
lated nanodots at Ag:peptide molar ratios of 0.1 :1 were pro-
duced without chemical reducing agents. These ratios yielded 30 
many more fluorescent species than do the higher ratios nec-
essary for nanodot production within other scaffolds. At 
equivalent scaffold concentrations, 3:1 Ag:dendrimer ratios 
are necessary for dendrimer encapsulation, and much larger 
ratios (with higher Ag concentrations) are necessary to pro- 35 
duce fluorescence from BSA (bovine serum albumin), both 
results strongly suggestive that the peptide preferentially 
binds the nanoclusters. Such preliminary results indicate that 
non-specific labeling should not be problematic due to the 
extremely strong peptide-silver interaction, even for this 40 
unoptimized peptide. Additionally, using this peptide, fluo-
rescence images are devoid of nearly all red and orange emit-
ters, indicating a narrower fluorescence distribution than 
those nanodots stabilized by the larger dendrimers. Thus, the 
stronger and more specific binding of even this first attempt at 45 
peptide encapsulation preferentially creates shorter wave-
length-emitting (and presumably smaller) Ag nanoclusters 
within the peptide scaffold with a narrower size distribution. 
This result strongly bolsters the hypotheses that highly selec-
tive nanodot-binding peptides can be identified through the 50 
proposed screening methods, and that different peptides are 
likely to stabilize nanodots of different sizes/colors. 
20 ecules are assessed. By creating and searching peptide librar-
ies for Ag nanodot fluorescence, the most tightly binding 
sequences are identified. Nanodots formed within these 
sequences are assayed for stability, photoactivation, and pho-
tophysical properties. The relative stability will also be 
25 assessed relative to the dendrimer hosts. In this manner, trans-
fer of the nanocluster is investigated between the dendrimer 
and the peptides. 
Extremely small, highly fluorescent and incredibly photo-
stable, water-soluble Ag nanodots were produced consisting 
of only a few atoms encapsulated by both PAMAM dendrim- 55 
ers and short peptides. The extremely advantageous optical 
properties have yielded incredibly photostable and strongly 
absorbing and emitting species with size-dependent emission 
throughout the visible region. One can utilize single molecule 
microscopies and water-soluble noble metal nanoclusters to 60 
create and characterize even more powerful labeling methods 
and materials. These specific, multicolored labels enable 
single molecule experiments with high sensitivity, greatly 
enhanced ease, and experimental simplicity. New fluorescent 
probe developments of this type are crucial to the general 65 
applicability and utility of single molecule methods in unrav-
eling the complexities of biological systems. 
Experimental Approach 
Many protein-ligand interaction studies make use of the 
phage display technique for identifying peptides that bind to 
other molecules (Wolcke & Weinhold, Nucleosides Nucle-
otides Nucleic Acids 2001, 20:1239-41; Krook et al., Bio-
chem Biophys Res Commun 1994, 204:849-54; Nicholls et 
al., J. Molecular Recognition 1996, 9:652-7 (1996); Stem & 
Gershoni, Methods Mo!. Biol. 1998, 87, 137-54).Althougha 
powerful approach, phage display requires one of the inter-
action components to be immobilized on solid surfaces. 
Application of phage-based peptide library screening has also 
recently been demonstrated in the synthesis and stabilization 
of unique inorganic materials (Whaley et al., Nature 2000, 
405:665-668; Lee et al., Science 2002, 296:892-895; Seeman 
& Belcher, Proc. Natl.Acad. Sci. USA 2002, 99:6451-6455). 
Because the target peptides will stabilize strong Ag nanoclus-
ter fluorescence in solution, Agn -binding peptides are identi-
fied with an E. coli based system (FliTrx random peptide 
display library, Invitrogen) coupled with fluorescence-acti-
vated cell sorting (FACS). The combination of the two tech-
niques will allow a solution based screening strategy. The 
FliTrx peptide library displays peptides on the surface of E. 
coli using the major bacterial flagellar protein (FliC) and 
thioredoxin (TrxA). The commercially available FliTrx 
library is composed of a diverse set of random dodecapep-
tides inserted into the active site loop ofthioredoxin, which is 
itself inserted into the dispensable region of the flagellin. The 
random dodecapeptides are constrained by a disulfide bond 
formed within TrxA. Adding tryptophan to the culture can 
induce the expression of peptide protein fusion, and this will 
ensure that all peptide fusions are displayed at the same time. 
When induced, the fusion protein is exported and assembled 
into flagella on the bacterial cell surface, allowing display of 
the constrained peptide. As these peptides are produced on the 
outside of the E. coli cell in high copy numbers, it is these 
peptides that will be assayed for stabilization of Ag nanodot 
fluorescence. The population of bacteria is then sorted 
according to the fluorescence properties with flow cytometry 
to isolate those bacteria emitting fluorescence. 
US 7,611,907 B2 
33 
Optimization of Agn Nanodot Production on Displayed 
FliTrx Peptides 
34 
fluorescence intensity distribution. Three fluorescence 
detecting channels are available: FL!, 530 nm with a 30 nm 
width, FL2, 585 nm with a 42 nm width, and FL3, 650 nm and 
above, each or combinations of which can be utilized for cell 
sorting. It is expected the majority of the bacteria with Ag 
nanocluster non-binding peptides will have minimal fluores-
cence and only those with significant fluorescence will be 
recovered. However, the intensity of fluorescence in each 
channel will be used in conjunction with the forward scatter to 
Optimal photoreduction conditions for peptide encapsu-
lated nanodot formation on the bacterial surface are deter-
mined through optical microscopy using the previously iden-
tified Agn (see Example 7). An oligonucleotide encoding the 
nonopeptide sequence and flanking Bg!II and EcoRV recog-
nition sequences is synthesized (Operon Co.) and cloned into 
the multicloning sites of the pFliTrx vector obtained from 
Invitrogen Co. This construct will insert the peptide into the 
nonessential region of flagellin as described above. The plas-
mid is isolated and transformed into the host strain GI826 
(Invitrogen) resulting in the display of the peptide on the 
surface of E. coli. This strain is then used to identify photo-
activation and chemical reduction conditions suitable for cre-
ating fluorescent peptide-encapsulated Ag nanodots when 
screening the FliTrx libraries with FACS. Cell viability is 
assessed when illuminated with blue light and when exposed 
10 
identify highly fluorescent cells resulting from Agn binding 
and stabilization. The collected bacteria will be plated out on 
ampicillin selection agar plates to isolate single colonies. 
Each single colony will be saved and tested again with flow 
cytometry and optical microscopy to confirm the associated 
fluorescence phenotype. Once the intensity of fluorescence is 
to BH4 - reduction as well as the efficiency of generating Ag 
nanodots. Initially, the total fluorescence from individual bac-
teria will be measured as a function of photoreduction time 
for many different Ag+ concentrations through optical 
microscopy. This procedure is quite straightforward and con-
sists of photochemically reducing Ag ions with electron 
donors in solution (Tani & Murofushi, J. Imag. Sci. Technol. 
1994, 98:1-9; Stellacci et al., Adv. Mater. 2002, 14:194; 
Eachus et al., Annu. Rev. Phys. Chem. 1999, 50:117-144). 
This procedure works well due to the advantageous energy 
levels of Ag relative to those of electronically excited mol-
ecules (Tani & Murofushi, J. Imag. Sci. Technol. 1994, 98:1-
15 determined, plasmid DNA will be isolated from those bacte-
ria with bright nanodot fluorescence and the peptide sequence 
determined by direct sequencing analysis. Alignment of 
sequences from the positive clones may generate a contigu-
ous consensus peptide sequence; alternatively, a structural 
20 motif formed by discontinuous conserved residues may be 
recognized. The defined sequences will be synthesized by 
solid phase peptide synthesis, and its binding properties to the 
Ag nanodots characterized using fluorescence microscopy, 
photophysical characterizations and mass spectrometry, 
25 similar to the studies discussed above. 
9; Marchetti et al., J. Phys. Chem. B 1998, 102:5287-5297; 30 
Stellacci et al., Adv. Mater. 2002, 14: 194; Eachus et al., Annu. 
Rev. Phys. Chem. 1999, 50:117-144). Photoreduction pro-
vides the opportunity to control the nanocluster size and color 
due to the different reduction potentials for Ag nanoclusters 
composed of only a few atoms (i.e. Ag2 _8). Alternatively, 35 
chemical reduction can be employed by slowly adding up to 
an equivalent ofNaBH4 or other reducing agents, thereby also 
yielding fluorescent nanodots. The conditions producing the 
most highly fluorescent Ag nanodot labeled E. coli cells will 
be the initial conditions for all library searching studies. 
Using the strong fluorescence producing conditions identi- 40 
fied, the fluorescent bacterial culture will be washed and 
subsequently suspended in phosphate buffer for FACS analy-
sis. This washed suspension of E. coli will also be re-assayed 
for total fluorescence on the microscope stage to assess the 
stability of fluorescence residing on the bacterial surface dur- 45 
ing the process of sample preparation. 
Identification of Specific Ag Nanodot Binding Sequence 
Through Random Peptide Display Libraries 
Creating User-Defined Libraries into FliTrx Peptide Display 
System 
An alternative to the use of a commercial library screen, 
flagellin display libraries can be generated with different 
peptide lengths using the pFliTrx vector. Degenerate oligo-
nucleotides of15 bp (5 a.a.), 27 bp (9 a.a.), 45 bp (15 a.a.), and 
60 bp (20 a.a.) flanked by Bg!II and EcoRV restriction rec-
ognition sequences will be synthesized (Operon Co.). The 
mixtures of oligonucleotides will be digested with these two 
enzymes and cloned into the pFliTrx vector, which has been 
cut with the same enzymes. The plasmid isolated from the 
collection of clones will then be transformed into the test 
strain G 1826, and the screening procedures repeated as 
described above. 
This method utilizes the natural diversity of the amino 
acids to select for specific Ag nanocluster binding to form a 
biocompatible, highly fluorescent nanodot. In many ways this 
is similar to the common method of genetically attaching a 
(His)ctag on the N- or C-terminus of a protein of interest to 
be purified through specific interaction with Ni. Analogously, 
the identifiedAgn-binding peptides defined in this study will 
specifically and selectively bind Ag nanoclusters, thereby 
enhancing their fluorescence. Additionally, the multiple fluo-
rescence detection channels in F ACS will also enable identi-
fication of a suite of peptides that preferentially stabilize 
50 different size, and therefore color, nanodots. A commercial display library (Invitro~en) will initially be 
used that contains a diversity of 1.8x10 to identify peptide 
sequences that interact specifically with Ag nanoclusters. 
Prepared libraries will be separated into 50 vials and frozen 
for individual analysis and optimization of Ag nanodot bind-
ing conditions as determined by total fluorescence. Each vial 
will contain most of the peptide library and will be assayed for 55 
optimal Agn binding conditions through a low magnification 
objective on the optical microscope stage. First, the library 
culture will be grown in the presence of tryptophan for 6 
hours to induce the expression of fusion flagellins. The cul-
ture will be washed with phosphate buffer and then incubated 60 
with silver nitrate to form Ag nanodots by photoreduction. 
Flow cytometry is capable of correlating cell/particle size 
with fluorescence. A dot plot of FSC (forward scatter, to 
define relative size) and SSC (side-scatter, to define relative 
granularity) will be generated (CellQuest program) to define 65 
a gate that specifies the bacterial population for sorting using 
FACS. The bacteria will be sorted according to the overall 
Characterization of Agn Nanocluster-Binding Peptides 
Once optimal peptide lengths and sequences are routinely 
identified and synthesized, environmental stabilities and pho-
tophysical properties of the fluorescent nanoclusters are 
directly assayed as described for the dendrimer-encapsulated 
nanodots above. While it is likely that specific sequences will 
preferentially stabilize specific nanocluster sizes with much 
narrower emission than possible in PAMAM dendrimer 
hosts, the same particle counting methods to identify the 
numbers of each type of nanocluster encapsulated within 
each flavor of peptide will be characterized. In fact, even in 
the preliminary peptide used that enables and stabilizes Ag 
nanodot fluorescence, a narrowing of the nanodot size distri-
bution is seen relative to that upon dendrimer encapsulation. 
Because of the affinity of Agn for more basic residues, larger 
nanoclusters will likely be preferentially stabilized by more 
basic sequences. This is likely to impart size and therefore 
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nanodot selectivity in peptide-Ag binding interactions. Con-
sequently, this genetic selection of Ag nanodot binding pep-
tides is likely to result in a variety of peptides, each of which 
stabilize different nanoclusters. This will result in a range of 
different programmable labels with different optical proper-
ties, each of which can be used as an independent single 
biomolecule label. Mass spectrometry (ESI and MALDI) will 
36 
be performed on all peptides that are synthesized and subse-
quently tested for Agn nanodot binding in order to determine 
the nanocluster size distribution within each identified Agn -
10 binding peptide and its correlation with the number of emit-
ters of a given color. This correlated single nanodot fluores-
cence microscopy, bulk absorption and emission, and mass 
spectrometry analysis for differing peptide and silver ion 
concentrations will directly characterize the binding con-
stants for each peptide identified through FACS library 15 
1999, 9:93-99; Bielinska et al., Biomaterials 2000, 21:877-
887; Luo et al., Macromolecules 2002, 35:3456-3462; Yoo et 
al., Pharm. Res. 1999, 16:1799-1804; Wiwattanapatapee et 
al, Phann. Res. 2000, 17:991-998; Esfand, & Tomalia, Drug 
Discov. Today 2001, 6:427-436), a valuable property in 
developing in vivo labeling experiments. As a result, the small 
PAMAM dendrimers are investigated as vehicles to transfer 
the Ag nanoclusters directly to the identified peptides that 
strongly bind Ag nanoclusters. Ag nanodot transfer is inves-
tigated with the same screening methods as peptide identifi-
cation and selection. Instead of optimizing silver ion concen-
trations for effective labeling of peptides within the FliTrx 
libraries, the dendrimer-encapsulated nanodot concentrations 
is adjusted while viewing solutions on the microscope stage 
(with a !Ox objective) to monitor nanodot exchange. Once 
conditions that label the E. coli cells are identified, peptide 
libraries are specifically screened for those cells containing screening. 
Example 9 
Transfer of Ag Nanoclusters Between Dendrimers 
and Peptides 
Because silver salts generally have very limited solubility 
in water, AgCl will likely precipitate out of a biologically 
relevant solution due to its very small solubility product and 
the large amount of chloride ions present in biological media. 
This presents a potential problem for delivering Agn nano-
clusters to the peptides defined in the studies proposed above, 
and may limit the direct delivery of highly fluorescent Ag 
nanoclusters. However, Ag nanoclusters were found to be 
very stable when encapsulated in the dendrimer hosts and 
retain their very bright fluorescence at physiological NaCl 
concentrations. Even the small 2nd generation PAMAM den-
drimer effectively shields the Ag nanoclusters from AgCl 
precipitation. In addition, dendrimers are well known to 
readily transport material contained within their interior 
across biological membranes (Toth et al., STP Pharma Sci. 
<160> NUMBER OF SEQ ID NOS, 2 
<210> SEQ ID NO 1 
<211> LENGTH, 9 
<212 > TYPE, PRT 
SEQUENCE LISTING 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
peptides capable of acquiring the nanodots from the dendrim-
ers. Because flow cytometry can select cells based on scatter 
and fluorescence, the very small dendrimers are undetectable 
20 in both channels. Only the cells are sufficiently large to scatter 
enough light to initiate collection, thereby avoiding false 
positives due to dendrimer-encapsulated nanodot fluores-
cence. Additionally, each bacterium within the FliTrx library 
has thousands of peptide copies, thus providing the potential 
25 for much stronger fluorescence signals. Only those cells 
exhibiting strong fluorescence and scattered light are col-
lected, grown with ampicillin selection, and sequenced. Such 
dendrimer to peptide library nanodot transfer is likely to be 
favored for lower generation PAMAM dendrimers under spe-
30 cific environmental conditions, such as specific pH's at which 
the dendrimer-encapsulated nanodots can more easily 
escape. The most pH-stable peptide-encapsulated nanodots 
are therefore likely to be of great utility in future labeling 
experiments. This additional screening method will further 
select for peptides that will preferentially extract Ag nano-
35 clusters from the dendrimer, opening possibilities for facile 
labeling of proteins both in vitro and in vivo. 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
peptide 
<400> SEQUENCE, 1 
Ala His His Ala His His Ala Ala Asp 
1 5 
<210> SEQ ID NO 2 
<211> LENGTH, 
<212 > TYPE, PRT 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, 6X-His tag 
<400> SEQUENCE, 2 
His His His His His His 
1 5 
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We claim: 
1. A method of monitoring a molecule of interest compris-
ing: a) attaching a water-soluble fluorescent label comprising 
an encapsulated noble metal nanocluster to a molecule of 
interest, wherein the noble metal nanocluster is about 0.1 nm 
to 2 nm in diameter without encapsulation, and wherein the 
fluorescent label exhibits an emission spectrum; and b) 
detecting the emission spectrum of the fluorescent label, and 
c) correlating the detected fluorescent emission spectrum to 
the presence of the attached molecule of interest, thereby 10 
monitoring the molecule of interest. 
2. The method of claim 1, wherein the noble metal nano-
cluster comprises between 2 and 8 noble metal atoms. 
3. The method of claim 1, wherein the noble metal is 
selected from the group consisting of gold, silver, and copper. 15 
4. The method of claim 1, wherein the encapsulated noble 
metal nanocluster fluoresces at a low excitation intensity and 
wherein the encapsulated noble metal nanocluster has a satu-
ration intensity ranging from approximately 1 to 1000 W /cm2 
at a nanocluster excitation maximum. 20 
5. The method of claim 4, wherein the low excitation inten-
sity at approximately 460 nm. 
6. The method of claim 1, wherein the fluorescent label 
exhibits a polarized spectral emission and exhibits a dipole 25 
emission pattern. 
38 
approximately 300 W/cm2 at 514.5 nm or 476 nm, and 
wherein the fluorescence is a saturated or an unsaturated 
fluorescence. 
13. The method of claim 1, further comprising the initial 
step of attaching a linker molecule to the encapsulated noble 
metal nanocluster, wherein the linker molecule is capable of 
attaching the fluorescent label to the molecule of interest. 
14. Themethodofclaiml, wherein themoleculeofinterest 
is present in a biological sample. 
15. The method of claim 1, wherein the size of the fluores-
cent label is from approximately less than 1 nm to 15 nm in 
diameter. 
16. The method of claim 1, wherein the noble metal nano-
cluster is encapsulated in a dendrimer. 
17. The method of claim 16, wherein the dendrimer com-
prises poly (amidoamine). 
18. The method of claim 17, wherein the poly(amidoam-
ine) dendrimer is selected from the group consisting of a oth 
generation, 1st generation, 2nd generation, 3rd generation, a 4th 
generation, and a higher generation poly(amidoamine) den-
drimer. 
19. The method of claim 17, wherein the poly(amidoam-
ine) dendrimer is a 2nd generation, or a 4th generation OH-
terminated poly(amidoamine) dendrimer. 
20. The method of claim 1, wherein the noble metal nano-
cluster is encapsulated in a peptide. 
21. The method of claim 20, wherein the peptide is 
expressed in a cell. 
7. The method of claim 1, wherein the fluorescent label has 
a spectral emission that provides information about a biologi-
cal state. 22. The method of claim 20, wherein the peptide comprises 
30 a fusion polypeptide. 8. The method of claim 7, wherein the biological state is 
selected from the group consisting of a quantitative and quali-
tative presence of a biological moiety; structure, composition, 
and conformation of a biological moiety; localization of a 
biological moiety in an environment; an interaction between 
biological moieties, an alteration in structure of a biological 35 
compound, and an alteration in a cellular process. 
9. The method of claim 1, wherein when the fluorescent 
label is excited, it is capable of fluorescing over a pH range of 
approximately 3 to 9. 
10. The method of claim 1, wherein the noble metal nano-
cluster emits greater than approximately 106 photons before 
photo bleaching. 
11. The method of claim 1, wherein when a composition 
comprising more than one noble metal nanocluster is excited, 
greater than approximately 80% of the noble metal nanoclus-
ters fluoresce for greater than approximately 30 minutes. 
12. The method of claim 11, wherein the noble metal 
nanoclusters fluoresce at a continuous excitation intensity of 
23. The method of claim 20, wherein the peptide is from 
approximately 5-500 amino acids in length. 
24. The method of claim 20, wherein the peptide is from 
approximately 5-20 amino acids in length. 
25. The method of claim 20, wherein the peptide is from 
approximately 20-40 amino acids in length. 
26. The method of claim 20, wherein the peptide comprises 
a polypeptide sequence as defined in SEQ ID NO: 1. 
27. The method of claim 1, wherein the noble metal nano-
40 cluster is less than about 1 nm in diameter prior to encapsu-
lation. 
28. The method of claim 1, wherein the noble metal nano-
cluster comprises between 2 and 27 noble metal atoms. 
29. The method of claim 1, wherein the noble metal nano-
45 cluster comprises between 2 and 20 noble metal atoms. 
30. The method of claim 1, wherein the noble metal nano-
cluster comprises between 2 and 15 noble metal atoms. 
* * * * * 
UNITED STATES PATENT AND TRADEMARK OFFICE 
CERTIFICATE OF CORRECTION 
PATENT NO. 
APPLICATION NO. 
DATED 
INVENTOR(S) 
: 7,611,907 B2 
: 10/519267 
: November 3, 2009 
: Dickson et al. 
Page 1of1 
It is certified that error appears in the above-identified patent and that said Letters Patent is hereby corrected as shown below: 
At column 1, line 3, insert the following: 
--STATEMENT OF GOVERNMENT INTEREST 
This invention was made with Government support under Grant No. BES-0323453, awarded by 
National Science Foundation and under Grant No. R 01 GM68732-0l, awarded by National Institutes 
of Health. The Government has certain rights in the invention.--
Signed and Sealed this 
Thirteenth Day of March, 2012 
David J. Kappos 
Director of the United States Patent and Trademark Office 
